ESC clinical practice guidelines for the management of acute myocardial infarction in patients with ST segment elevation;Guía de práctica clínica de la ESC para el manejo del infarto agudo de miocardio en pacientes con elevación del segmento ST: Grupo de Trabajo para el manejo del infarto agudo de miocardio con elevación del segmento ST de la Sociedad Europea de Cardiología (ESC)

Revista Espanola de Cardiologia

Volumn 66, Issue 1, 2013, Pages

  Steg, Gabriel ^a   James, Stefan K ^a   Atar, Dan ^b   Badano, Luigi P ^b   Blomstrom Lundqvist, Carina ^b   Borger, Michael A ^b   Di Mario, Carlo ^b   Dickstein, Kenneth ^b   Ducrocq, Gregory ^b   Fernández Avilés, Francisco ^b   Gershlick, Anthony H ^b   Giannuzzi, Pantaleo ^b   Halvorsen, Sigrun ^b   Huber, Kurt ^b   Juni, Peter ^b   Kastrati, Adnan ^b   Knuuti, Juhani ^b   Lenzen, Mattie J ^b   W Mahaffey, Kenneth ^b   Valgimigli, Marco ^b   Van'T Hof, Arnoud ^b   Widimsky, Petr ^b   Zahger, Doron ^b   Bax, Jeroen J ^b   Baumgartner, Helmut ^b   Ceconi, Claudio ^b   Dean, Veronica ^b   Deaton, Christi ^b   Fagard, Robert ^b   Funck Brentano, Christian ^b   Hasdai, David ^b   Hoes, Arno ^b   Kirchhof, Paulus ^b   Kolh, Philippe ^b   McDonagh, Theresa ^b   Moulin, Cyril ^b   Popescu, Bogdan A ^b   Reiner, Zeljko ^b   Sechtem, Udo ^b   Sirnes, Per Anton ^b   Tendera, Michal ^b   Torbicki, Adam ^b   Vahanian, Alec ^b   Windecker, Stephan ^b   Astin, Felicity ^b   Astrom Olsson, Karin ^b   Budaj, Andrzej ^b   Clemmensen, Peter ^b   Collet, Jean Philippe ^b   Fox, Keith A ^b   Fuat, Ahmet ^b   Gustiene, Olivija ^b   Hamm, Christian W ^b   Kala, Petr ^b   Lancellotti, Patrizio ^b   Pietro Maggioni, Aldo ^b   Merkely, Béla ^b   Neumann, Franz Josef ^b   Piepoli, Massimo F ^b   Werf, Frans Van De ^b   Verheugt, Freek ^b   Wallentin, Lars ^b   more..

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ARTICLE; HUMAN; PRACTICE GUIDELINE; ST SEGMENT ELEVATION;

EID: 84871821451     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2012.10.014     Document Type: Article

References (345)

1. F. Van de Werf, J. Bax, A. Betriu, C. Blomstrom-Lundqvist, F. Crea, V. Falk, G. Filippatos, K. Fox, K. Huber, A. Kastrati, A. Rosengren, P.G. Steg, M. Tubaro, F. Verheugt, F. Weidinger, M. Weis, A. Vahanian, J. Camm, R. De Caterina, V. Dean, K. Dickstein, C. Funck-Brentano, I. Hellemans, S.D. Kristensen, K. McGregor, U. Sechtem, S. Silber, M. Tendera, P. Widimsky, J.L. Zamorano, F.V. Aguirre, N. Al-Attar, E. Alegria, F. Andreotti, W. Benzer, O. Breithardt, N. Danchin, C. Di Mario, D. Dudek, D. Gulba, S. Halvorsen, P. Kaufmann, R. Kornowski, G.Y. Lip, and F. Rutten Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology Eur Heart J 29 2008 2909 2945
2. K. Thygesen, J.S. Alpert, and H.D. White Universal definition of myocardial infarction Eur Heart J 28 2007 2525 2538 (Pubitemid 47616190)
3. C.W. Hamm, J.P. Bassand, S. Agewall, J. Bax, E. Boersma, H. Bueno, P. Caso, D. Dudek, S. Gielen, K. Huber, M. Ohman, M.C. Petrie, F. Sonntag, M.S. Uva, R.F. Storey, W. Wijns, D. Zahger, J.J. Bax, A. Auricchio, H. Baumgartner, C. Ceconi, V. Dean, C. Deaton, R. Fagard, C. Funck-Brentano, D. Hasdai, A. Hoes, J. Knuuti, P. Kolh, T. McDonagh, C. Moulin, D. Poldermans, B.A. Popescu, Z. Reiner, U. Sechtem, P.A. Sirnes, A. Torbicki, A. Vahanian, S. Windecker, S. Windecker, S. Achenbach, L. Badimon, M. Bertrand, H.E. Botker, J.P. Collet, F. Crea, N. Danchin, E. Falk, J. Goudevenos, D. Gulba, R. Hambrecht, J. Herrmann, A. Kastrati, K. Kjeldsen, S.D. Kristensen, P. Lancellotti, J. Mehilli, B. Merkely, G. Montalescot, F.J. Neumann, L. Neyses, J. Perk, M. Roffi, F. Romeo, M. Ruda, E. Swahn, M. Valgimigli, C.J. Vrints, and P. Widimsky ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC) Eur Heart J 32 2011 2999 3054
4. W. Wijns, P. Kolh, N. Danchin, C. Di Mario, V. Falk, T. Folliguet, S. Garg, K. Huber, S. James, J. Knuuti, J. Lopez-Sendon, J. Marco, L. Menicanti, M. Ostojic, M.F. Piepoli, C. Pirlet, J.L. Pomar, N. Reifart, F.L. Ribichini, M.J. Schalij, P. Sergeant, P.W. Serruys, S. Silber, M. Sousa Uva, D. Taggart, A. Vahanian, A. Auricchio, J. Bax, C. Ceconi, V. Dean, G. Filippatos, C. Funck-Brentano, R. Hobbs, P. Kearney, T. McDonagh, B.A. Popescu, Z. Reiner, U. Sechtem, P.A. Sirnes, M. Tendera, P.E. Vardas, P. Widimsky, O. Alfieri, J. Dunning, S. Elia, P. Kappetein, U. Lockowandt, G. Sarris, P. Vouhe, L. von Segesser, S. Agewall, A. Aladashvili, D. Alexopoulos, M.J. Antunes, E. Atalar, A. Brutel de la Riviere, A. Doganov, J. Eha, J. Fajadet, R. Ferreira, J. Garot, J. Halcox, Y. Hasin, S. Janssens, K. Kervinen, G. Laufer, V. Legrand, S.A. Nashef, F.J. Neumann, K. Niemela, P. Nihoyannopoulos, M. Noc, J.J. Piek, J. Pirk, Y. Rozenman, M. Sabate, R. Starc, M. Thielmann, D.J. Wheatley, S. Windecker, and M. Zembala Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Eur Heart J 31 2010 2501 2555
5. WHO Fact sheet N.°310, updated June 2011. Disponible en: http://www.who.int/mediacentre/factsheets/fs310/en/index.html.
6. P. Widimsky, W. Wijns, J. Fajadet, M. de Belder, J. Knot, L. Aaberge, G. Andrikopoulos, J.A. Baz, A. Betriu, M. Claeys, N. Danchin, S. Djambazov, P. Erne, J. Hartikainen, K. Huber, P. Kala, M. Klinceva, S.D. Kristensen, P. Ludman, J.M. Ferre, B. Merkely, D. Milicic, J. Morais, M. Noc, G. Opolski, M. Ostojic, D. Radovanovic, S. De Servi, U. Stenestrand, M. Studencan, M. Tubaro, Z. Vasiljevic, F. Weidinger, A. Witkowski, and U. Zeymer Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries Eur Heart J 31 2010 943 957
7. P. Widimsky, M. Zelizko, P. Jansky, F. Tousek, F. Holm, and M. Aschermann The incidence, treatment strategies, outcomes of acute coronary syndromes in the "reperfusion network" of different hospital types in the Czech Republic: results of the Czech evaluation of acute coronary syndromes in hospitalized patients (CZECH) registry Int J Cardiol 119 2007 212 219 (Pubitemid 46818534)
8. D.D. McManus, J. Gore, J. Yarzebski, F. Spencer, D. Lessard, and R.J. Goldberg Recent trends in the incidence, treatment, and outcomes of patients with STEMI and NSTEMI Am J Med 124 2011 40 47
9. V.L. Roger, A.S. Go, D.M. Lloyd-Jones, E.J. Benjamin, J.D. Berry, W.B. Borden, D.M. Bravata, S. Dai, E.S. Ford, C.S. Fox, H.J. Fullerton, C. Gillespie, S.M. Hailpern, J.A. Heit, V.J. Howard, B.M. Kissela, S.J. Kittner, D.T. Lackland, J.H. Lichtman, L.D. Lisabeth, D.M. Makuc, G.M. Marcus, A. Marelli, D.B. Matchar, C.S. Moy, D. Mozaffarian, M.E. Mussolino, G. Nichol, N.P. Paynter, E.Z. Soliman, P.D. Sorlie, N. Sotoodehnia, T.N. Turan, S.S. Virani, N.D. Wong, D. Woo, and M.B. Turner Executive summary: heart disease and stroke statistics - 2012 update: a report from the American Heart Association Circulation 125 2012 188 197
10. L. Mandelzweig, A. Battler, V. Boyko, H. Bueno, N. Danchin, G. Filippatos, A. Gitt, D. Hasdai, Y. Hasin, J. Marrugat, F. Van de Werf, L. Wallentin, and S. Behar The second Euro Heart Survey on acute coronary syndromes: characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004 Eur Heart J 27 2006 2285 2293 (Pubitemid 44453571)
11. T. Jernberg, P. Johanson, C. Held, B. Svennblad, J. Lindback, and L. Wallentin Association between adoption of evidence-based treatment and survival for patients with ST-elevation myocardial infarction J Am Med Assoc 305 2011 1677 1684
12. K.A. Fox, P.G. Steg, K.A. Eagle, S.G. Goodman, F.A. Anderson Jr., C.B. Granger, M.D. Flather, A. Budaj, A. Quill, and J.M. Gore Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006 J Am Med Assoc 297 2007 1892 1900 (Pubitemid 46707843)
13. K.A. Fox, O.H. Dabbous, R.J. Goldberg, K.S. Pieper, K.A. Eagle, F. Van de Werf, A. Avezum, S.G. Goodman, M.D. Flather, F.A. Anderson Jr., and C.B. Granger Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE) Br Med J 333 2006 1091
14. K.A. Fox, K.F. Carruthers, D.R. Dunbar, C. Graham, J.R. Manning, H. De Raedt, I. Buysschaert, D. Lambrechts, and F. Van de Werf Underestimated and underrecognized: the late consequences of acute coronary syndrome (GRACE UK-Belgian Study) Eur Heart J 31 2010 2755 2764
15. M. Tubaro, N. Danchin, P. Goldstein, G. Filippatos, Y. Hasin, M. Heras, P. Jansky, T.M. Norekval, E. Swahn, K. Thygesen, C. Vrints, D. Zahger, H.R. Arntz, A. Bellou, J.E. De La Coussaye, L. De Luca, K. Huber, Y. Lambert, M. Lettino, B. Lindahl, S. McLean, L. Nibbe, W.F. Peacock, S. Price, T. Quinn, C. Spaulding, G. Tatu-Chitoiu, and F. Van DeWerf Pre-hospital treatment of STEMI patients. A scientific statement of the Working Group Acute Cardiac Care of the European Society of Cardiology Acute Card Care 13 2011 56 67
16. D. Brieger, K.A. Eagle, S.G. Goodman, P.G. Steg, A. Budaj, K. White, and G. Montalescot Acute coronary syndromes without chest pain, an underdiagnosed and undertreated high-risk group: insights from the Global Registry of Acute Coronary Events Chest 126 2004 461 469 (Pubitemid 39093431)
17. D.B. Diercks, W.F. Peacock, B.C. Hiestand, A.Y. Chen, C.V. Pollack Jr., J.D. Kirk, S.C. Smith Jr., W.B. Gibler, E.M. Ohman, A.L. Blomkalns, L.K. Newby, J.S. Hochman, E.D. Peterson, and M.T. Roe Frequency and consequences of recording an electrocardiogram >10 minutes after arrival in an emergency room in non-ST-segment elevation acute coronary syndromes (from the CRUSADE Initiative) Am J Cardiol 97 2006 437 442 (Pubitemid 43192015)
18. J. Lopez-Sendon, I. Coma-Canella, S. Alcasena, J. Seoane, and C. Gamallo Electrocardiographic findings in acute right ventricular infarction: sensitivity and specificity of electrocardiographic alterations in right precordial leads V4R, V3R, V1, V2, and V3 J Am Coll Cardiol 6 1985 1273 1279 (Pubitemid 16171973)
19. I.C. Rokos, W.J. French, W.J. Koenig, S.J. Stratton, B. Nighswonger, B. Strunk, J. Jewell, E. Mahmud, J.V. Dunford, J. Hokanson, S.W. Smith, K.W. Baran, R. Swor, A. Berman, B.H. Wilson, A.O. Aluko, B.W. Gross, P.S. Rostykus, A. Salvucci, V. Dev, B. McNally, S.V. Manoukian, and S.B. King 3rd. Integration of pre-hospital electrocardiograms and ST-elevation myocardial infarction receiving center (SRC) networks: impact on door-to-balloon times across 10 independent regions JACC Cardiovasc Interv 2 2009 339 346
20. M. O'Doherty, D.I. Tayler, E. Quinn, R. Vincent, and D.A. Chamberlain Five hundred patients with myocardial infarction monitored within one hour of symptoms Br Med J (Clin Res Ed) 286 1983 1405 1408 (Pubitemid 13128635)
21. R.H. Mehta, A.Z. Starr, R.D. Lopes, J.S. Hochman, P. Widimsky, K.S. Pieper, P.W. Armstrong, and C.B. Granger Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention J Am Med Assoc 301 2009 1779 1789
22. E.B. Sgarbossa, S.L. Pinski, A. Barbagelata, D.A. Underwood, K.B. Gates, E.J. Topol, R.M. Califf, and G.S. Wagner Electrocardiographic diagnosis of evolving acute myocardial infarction in the presence of left bundle-branch block. GUSTO-1 (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries) investigators N Engl J Med 334 1996 481 487
23. M.G. Shlipak, W.L. Lyons, A.S. Go, T.M. Chou, G.T. Evans, and W.S. Browner Should the electrocardiogram be used to guide therapy for patients with left bundle-branch block and suspected myocardial infarction? JAMA 281 1999 714 719 (Pubitemid 29113452)
24. R.D. Lopes, H. Siha, Y. Fu, R.H. Mehta, M.R. Patel, P.W. Armstrong, and C.B. Granger Diagnosing acute myocardial infarction in patients with left bundle branch block Am J Cardiol 108 2011 782 788
25. P. Widimsky, F. Rohac, J. Stasek, P. Kala, R. Rokyta, B. Kuzmanov, M. Jakl, M. Poloczek, J. Kanovsky, I. Bernat, O. Hlinomaz, J. Belohlavek, A. Kral, V. Mrazek, V. Grigorov, S. Djambazov, R. Petr, J. Knot, D. Bilkova, M. Fischerova, K. Vondrak, M. Maly, and A. Lorencova Primary angioplasty in acute myocardial infarction with right bundle branch block: should new onset right bundle branch block be added to future guidelines as an indication for reperfusion therapy? Eur Heart J 33 2012 86 95
26. A. Krishnaswamy, A.M. Lincoff, and V. Menon Magnitude and consequences of missing the acute infarct-related circumflex artery Am Heart J 158 2009 706 712
27. A.M. From, P.J. Best, R.J. Lennon, C.S. Rihal, and A. Prasad Acute myocardial infarction due to left circumflex artery occlusion and significance of ST-segment elevation Am J Cardiol 106 2010 1081 1085
28. A.T. Yan, R.T. Yan, B.M. Kennelly, F.A. Anderson Jr., A. Budaj, J. Lopez-Sendon, D. Brieger, J. Allegrone, G. Steg, and S.G. Goodman Relationship of ST elevation in lead aVR with angiographic findings and outcome in non-ST elevation acute coronary syndromes Am Heart J 154 2007 71 78 (Pubitemid 46920481)
29. Y.J. Akashi, D.S. Goldstein, G. Barbaro, and T. Ueyama Takotsubo cardiomyopathy: a new form of acute, reversible heart failure Circulation 118 2008 2754 2762
30. J.B. Cabello, A. Burls, J.I. Emparanza, S. Bayliss, and T. Quinn Oxygen therapy for acute myocardial infarction Cochrane Database Syst Rev 6 2010 CD007160
31. C.M. Spaulding, L.M. Joly, A. Rosenberg, M. Monchi, S.N. Weber, J.F. Dhainaut, and P. Carli Immediate coronary angiography in survivors of out-of-hospital cardiac arrest N Engl J Med 336 1997 1629 1633 (Pubitemid 27231316)
32. K.B. Kern, and O. Rahman Emergent percutaneous coronary intervention for resuscitated victims of out-of-hospital cardiac arrest Catheter Cardiovasc Interv 75 2010 616 624
33. P. Garot, T. Lefevre, H. Eltchaninoff, M.C. Morice, F. Tamion, B. Abry, P.F. Lesault, J.Y. Le Tarnec, C. Pouges, A. Margenet, M. Monchi, I. Laurent, P. Dumas, J. Garot, and Y. Louvard Six-month outcome of emergency percutaneous coronary intervention in resuscitated patients after cardiac arrest complicating ST-elevation myocardial infarction Circulation 115 2007 1354 1362 (Pubitemid 46661479)
34. S.A. Bernard, T.W. Gray, M.D. Buist, B.M. Jones, W. Silvester, G. Gutteridge, and K. Smith Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia N Engl J Med 346 2002 557 563 (Pubitemid 34438816)
35. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med. 2002;346:549-56.
36. G. Belliard, E. Catez, C. Charron, V. Caille, P. Aegerter, O. Dubourg, F. Jardin, and A. Vieillard-Baron Efficacy of therapeutic hypothermia after out-of-hospital cardiac arrest due to ventricular fibrillation Resuscitation 75 2007 252 259 (Pubitemid 47588627)
37. J.P. Nolan, J. Soar, D.A. Zideman, D. Biarent, L.L. Bossaert, C. Deakin, R.W. Koster, J. Wyllie, and B. Bottiger European Resuscitation Council Guidelines for Resuscitation 2010 Section 1. Executive summary Resuscitation 81 2010 1219 1276
38. R.V. Luepker, J.M. Raczynski, S. Osganian, R.J. Goldberg, J.R. Finnegan Jr., J.R. Hedges, D.C. Goff Jr., M.S. Eisenberg, J.G. Zapka, H.A. Feldman, D.R. Labarthe, P.G. McGovern, C.E. Cornell, M.A. Proschan, and D.G. Simons-Morton Effect of a community intervention on patient delay and emergency medical service use in acute coronary heart disease: The Rapid Early Action for Coronary Treatment (REACT) Trial JAMA 284 2000 60 67 (Pubitemid 30445662)
39. C.J. Terkelsen, J.T. Sorensen, M. Maeng, L.O. Jensen, H.H. Tilsted, S. Trautner, W. Vach, S.P. Johnsen, L. Thuesen, and J.F. Lassen System delay and mortality among patients with STEMI treated with primary percutaneous coronary intervention JAMA 304 2010 763 771
40. P.G. Steg, E. Bonnefoy, S. Chabaud, F. Lapostolle, P.Y. Dubien, P. Cristofini, A. Leizorovicz, and P. Touboul Impact of time to treatment on mortality after pre-hospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial Circulation 108 2003 2851 2856 (Pubitemid 37517811)
41. D.S. Pinto, A.J. Kirtane, B.K. Nallamothu, S.A. Murphy, D.J. Cohen, R.J. Laham, D.E. Cutlip, E.R. Bates, P.D. Frederick, D.P. Miller, J.P. Carrozza Jr., E.M. Antman, C.P. Cannon, and C.M. Gibson Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy Circulation 114 2006 2019 2025 (Pubitemid 44706877)
42. K. Huber, R. De Caterina, S.D. Kristensen, F.W. Verheugt, G. Montalescot, L.B. Maestro, and F. Van de Werf Pre-hospital reperfusion therapy: a strategy to improve therapeutic outcome in patients with ST-elevation myocardial infarction Eur Heart J 26 2005 2063 2074 (Pubitemid 41435730)
43. R.C. Welsh, W. Chang, P. Goldstein, J. Adgey, C.B. Granger, F.W. Verheugt, L. Wallentin, F. Van de Werf, and P.W. Armstrong Time to treatment and the impact of a physician on pre-hospital management of acute ST elevation myocardial infarction: insights from the ASSENT-3 PLUS trial Heart 91 2005 1400 1406 (Pubitemid 41531808)
44. N. Danchin, P. Coste, J. Ferrieres, P.G. Steg, Y. Cottin, D. Blanchard, L. Belle, B. Ritz, G. Kirkorian, M. Angioi, P. Sans, B. Charbonnier, H. Eltchaninoff, P. Gueret, K. Khalife, P. Asseman, J. Puel, P. Goldstein, J.P. Cambou, and T. Simon Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction: data from the French registry on acute ST-elevation myocardial infarction (FAST-MI) Circulation 118 2008 268 276
45. E. Bonnefoy, P.G. Steg, F. Boutitie, P.Y. Dubien, F. Lapostolle, J. Roncalli, F. Dissait, G. Vanzetto, A. Leizorowicz, G. Kirkorian, C. Mercier, E.P. McFadden, and P. Touboul Comparison of primary angioplasty and pre-hospital fibrinolysis in acute myocardial infarction (CAPTIM) trial: a 5-year follow-up Eur Heart J 30 2009 1598 1606
46. J.T. McMullan, W. Hinckley, J. Bentley, T. Davis, G.J. Fermann, M. Gunderman, K.W. Hart, W.A. Knight, C.J. Lindsell, C. Miller, A. Shackleford, and W. Brian Gibler Ground emergency medical services requests for helicopter transfer of ST-segment elevation myocardial infarction patients decrease medical contact to balloon times in rural and suburban settings Acad Emerg Med 19 2012 153 160
47. K. Kalla, G. Christ, R. Karnik, R. Malzer, G. Norman, H. Prachar, W. Schreiber, G. Unger, H.D. Glogar, A. Kaff, A.N. Laggner, G. Maurer, J. Mlczoch, J. Slany, H.S. Weber, and K. Huber Implementation of guidelines improves the standard of care: the Viennese registry on reperfusion strategies in ST-elevation myocardial infarction (Vienna STEMI registry) Circulation 113 2006 2398 2405 (Pubitemid 43948047)
48. T.D. Henry, S.W. Sharkey, M.N. Burke, I.J. Chavez, K.J. Graham, C.R. Henry, D.L. Lips, J.D. Madison, K.M. Menssen, M.R. Mooney, M.C. Newell, W.R. Pedersen, A.K. Poulose, J.H. Traverse, B.T. Unger, Y.L. Wang, and D.M. Larson A regional system to provide timely access to percutaneous coronary intervention for ST-elevation myocardial infarction Circulation 116 2007 721 728 (Pubitemid 47255989)
49. M.R. Le May, D.Y. So, R. Dionne, C.A. Glover, M.P. Froeschl, G.A. Wells, R.F. Davies, H.L. Sherrard, J. Maloney, J.F. Marquis, E.R. O'Brien, J. Trickett, P. Poirier, S.C. Ryan, A. Ha, P.G. Joseph, and M. Labinaz A citywide protocol for primary PCI in ST-segment elevation myocardial infarction N Engl J Med 358 2008 231 240
50. E.H. Bradley, J. Herrin, Y. Wang, B.A. Barton, T.R. Webster, J.A. Mattera, S.A. Roumanis, J.P. Curtis, B.K. Nallamothu, D.J. Magid, R.L. McNamara, J. Parkosewich, J.M. Loeb, and H.M. Krumholz Strategies for reducing the door-to-balloon time in acute myocardial infarction N Engl J Med 355 2006 2308 2320 (Pubitemid 44837779)
51. P. Widimsky, J. Fajadet, N. Danchin, and W. Wijns Stent 4 Life" targeting PCI at all who will benefit the most. A joint project between EAPCI, Euro-PCR, EUCOMED and the ESC Working Group on Acute Cardiac Care EuroIntervention 4 2009 555 557
52. J. Knot, P. Widimsky, W. Wijns, U. Stenestrand, S.D. Kristensen, T.H.A. Van, F. Weidinger, M. Janzon, B.L. Norgaard, J.T. Soerensen, H. van de Wetering, K. Thygesen, P.A. Bergsten, C. Digerfeldt, A. Potgieter, N. Tomer, and J. Fajadet How to set up an effective national primary angioplasty network: lessons learned from five European countries EuroIntervention 5 2009 301 309
53. H.H. Ting, H.M. Krumholz, E.H. Bradley, D.C. Cone, J.P. Curtis, B.J. Drew, J.M. Field, W.J. French, W.B. Gibler, D.C. Goff, A.K. Jacobs, B.K. Nallamothu, R.E. O'Connor, and J.D. Schuur Implementation and integration of pre-hospital ECGs into systems of care for acute coronary syndrome: a scientific statement from the American Heart Association Interdisciplinary Council on Quality of Care and Outcomes Research, Emergency Cardiovascular Care Committee, Council on Cardiovascular Nursing, and Council on Clinical Cardiology Circulation 118 2008 1066 1079
54. G. Amit, C. Cafri, H. Gilutz, R. Ilia, and D. Zahger Benefit of direct ambulance to coronary care unit admission of acute myocardial infarction patients undergoing primary percutaneous intervention Int J Cardiol 119 2007 355 358 (Pubitemid 46921268)
55. B.K. Nallamothu, H.M. Krumholz, D.T. Ko, K.A. LaBresh, S. Rathore, M.T. Roe, and L. Schwamm Development of systems of care for ST-elevation myocardial infarction patients: gaps, barriers, and implications Circulation 116 2007 e68 e72
56. S.S. Rathore, J.P. Curtis, J. Chen, Y. Wang, B.K. Nallamothu, A.J. Epstein, and H.M. Krumholz Association of door-to-balloon time and mortality in patients admitted to hospital with ST elevation myocardial infarction: national cohort study Br Med J 338 2009 b1807
57. P.H. Nielsen, C.J. Terkelsen, T.T. Nielsen, L. Thuesen, L.R. Krusell, P. Thayssen, H. Kelbaek, U. Abildgaard, A.B. Villadsen, H.R. Andersen, and M. Maeng System delay and timing of intervention in acute myocardial infarction (from the Danish Acute Myocardial Infarction-2 [DANAMI-2] trial) Am J Cardiol 108 2011 776 781
58. P.G. Steg, J.P. Cambou, P. Goldstein, E. Durand, P. Sauval, Z. Kadri, D. Blanchard, J.M. Lablanche, P. Gueret, Y. Cottin, J.M. Juliard, G. Hanania, L. Vaur, and N. Danchin Bypassing the emergency room reduces delays and mortality in ST elevation myocardial infarction: the USIC 2000 registry Heart 92 2006 1378 1383 (Pubitemid 44578821)
59. D. Hackett, G. Davies, S. Chierchia, and A. Maseri Intermittent coronary occlusion in acute myocardial infarction. Value of combined thrombolytic and vasodilator therapy N Engl J Med 317 1987 1055 1059 (Pubitemid 17146897)
60. A. Schomig, J. Mehilli, D. Antoniucci, G. Ndrepepa, C. Markwardt, F. Di Pede, S.G. Nekolla, K. Schlotterbeck, H. Schuhlen, J. Pache, M. Seyfarth, S. Martinoff, W. Benzer, C. Schmitt, J. Dirschinger, M. Schwaiger, and A. Kastrati Mechanical reperfusion in patients with acute myocardial infarction presenting more than 12 hours from symptom onset: a randomized controlled trial JAMA 293 2005 2865 2872 (Pubitemid 41029140)
61. G. Ndrepepa, A. Kastrati, J. Mehilli, D. Antoniucci, and A. Schomig Mechanical reperfusion and long-term mortality in patients with acute myocardial infarction presenting 12 to 48 hours from onset of symptoms JAMA 301 2009 487 488
62. J.S. Hochman, G.A. Lamas, C.E. Buller, V. Dzavik, H.R. Reynolds, S.J. Abramsky, S. Forman, W. Ruzyllo, A.P. Maggioni, H. White, Z. Sadowski, A.C. Carvalho, J.M. Rankin, J.P. Renkin, P.G. Steg, A.M. Mascette, G. Sopko, M.E. Pfisterer, J. Leor, V. Fridrich, D.B. Mark, and G.L. Knatterud Coronary intervention for persistent occlusion after myocardial infarction N Engl J Med 355 2006 2395 2407 (Pubitemid 44911017)
63. J.P. Ioannidis, and D.G. Katritsis Percutaneous coronary intervention for late reperfusion after myocardial infarction in stable patients Am Heart J 154 2007 1065 1071 (Pubitemid 350116046)
64. V. Menon, C.A. Pearte, C.E. Buller, P.G. Steg, S.A. Forman, H.D. White, P.N. Marino, D.G. Katritsis, P. Caramori, R. Lasevitch, K. Loboz-Grudzien, A. Zurakowski, G.A. Lamas, and J.S. Hochman Lack of benefit from percutaneous intervention of persistently occluded infarct arteries after the acute phase of myocardial infarction is time independent: insights from Occluded Artery Trial Eur Heart J 30 2009 183 211
65. E. Boersma, A.C. Maas, J.W. Deckers, and M.L. Simoons Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour Lancet 348 1996 771 775 (Pubitemid 26308479)
66. E. Boersma Does time matter?. A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients Eur Heart J 27 2006 779 788
67. M. Gierlotka, M. Gasior, K. Wilczek, M. Hawranek, J. Szkodzinski, P. Paczek, A. Lekston, Z. Kalarus, M. Zembala, and L. Polonski Reperfusion by primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction within 12 to 24 hours of the onset of symptoms (from a prospective national observational study [PL-ACS]) Am J Cardiol 107 2011 501 508
68. F. Zijlstra, J.C. Hoorntje, M.J. de Boer, S. Reiffers, K. Miedema, J.P. Ottervanger, A.W. van't Hof, and H. Suryapranata Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction N Engl J Med 341 1999 1413 1419 (Pubitemid 29513456)
69. E.C. Keeley, J.A. Boura, and C.L. Grines Primary angioplasty vs. intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials Lancet 361 2003 13 20 (Pubitemid 36050955)
70. P. Widimsky, T. Budesinsky, D. Vorac, L. Groch, M. Zelizko, M. Aschermann, M. Branny, J. St'asek, and P. Formanek Long distance transport for primary angioplasty vs. immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial - PRAGUE-2 Eur Heart J 24 2003 94 104 (Pubitemid 36109551)
71. H.R. Andersen, T.T. Nielsen, K. Rasmussen, L. Thuesen, H. Kelbaek, P. Thayssen, U. Abildgaard, F. Pedersen, J.K. Madsen, P. Grande, A.B. Villadsen, L.R. Krusell, T. Haghfelt, P. Lomholt, S.E. Husted, E. Vigholt, H.K. Kjaergard, and L.S. Mortensen A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction N Engl J Med 349 2003 733 742 (Pubitemid 37010777)
72. L.J. Morrison, P.R. Verbeek, A.C. McDonald, B.V. Sawadsky, and D.J. Cook Mortality and pre-hospital thrombolysis for acute myocardial infarction: A meta-analysis JAMA 283 2000 2686 2692 (Pubitemid 30337331)
73. E. Bonnefoy, F. Lapostolle, A. Leizorovicz, G. Steg, E.P. McFadden, P.Y. Dubien, S. Cattan, E. Boullenger, J. Machecourt, J.M. Lacroute, J. Cassagnes, F. Dissait, and P. Touboul Primary angioplasty vs. pre-hospital fibrinolysis in acute myocardial infarction: a randomised study Lancet 360 2002 825 829 (Pubitemid 35257945)
74. D.S. Pinto, P.D. Frederick, A.K. Chakrabarti, A.J. Kirtane, E. Ullman, A. Dejam, D.P. Miller, T.D. Henry, and C.M. Gibson Benefit of transferring ST-segment-elevation myocardial infarction patients for percutaneous coronary intervention compared with administration of onsite fibrinolytic declines as delays increase Circulation 124 2011 2512 2521
75. P. Widimsky, and D.R. Holmes Jr. How to treat patients with ST-elevation acute myocardial infarction and multi-vessel disease? Eur Heart J 32 2011 396 403
76. M.A. Cavender, S. Milford-Beland, M.T. Roe, E.D. Peterson, W.S. Weintraub, and S.V. Rao Prevalence, predictors, and in-hospital outcomes of non-infarct artery intervention during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (from the National Cardiovascular Data Registry) Am J Cardiol 104 2009 507 513
77. R. Kornowski, R. Mehran, G. Dangas, E. Nikolsky, A. Assali, B.E. Claessen, B.J. Gersh, S.C. Wong, B. Witzenbichler, G. Guagliumi, D. Dudek, M. Fahy, A.J. Lansky, and G.W. Stone Prognostic impact of staged vs. "one-time" multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (Harmonizing Outcomes with RevascularIZatiON and stents in Acute Myocardial Infarction) trial J Am Coll Cardiol 58 2011 704 711
78. S.S. Jolly, S. Yusuf, J. Cairns, K. Niemela, D. Xavier, P. Widimsky, A. Budaj, M. Niemela, V. Valentin, B.S. Lewis, A. Avezum, P.G. Steg, S.V. Rao, P. Gao, R. Afzal, C.D. Joyner, S. Chrolavicius, and S.R. Mehta Radial vs. femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial Lancet 377 2011 1409 1420
79. Romagnoli E, Biondi-Zoccai G, Sciahbasi A, Politi L, Rigattieri S, Pendenza G, Di Russo C, Summaria F, Patrizi R, Moretti C, Agostoni P, Loschiavo P, Lioy E, Sheiban I, Sangiorgi GM. Radial vs. femoral randomized investigation in ST elevation acute coronary syndromes: The RIFLE STEACS study. J Am Coll Cardiol. 2012 Jul 27.[Epub ahead of print].
80. A. Kastrati, A. Dibra, C. Spaulding, G.J. Laarman, M. Menichelli, M. Valgimigli, E. Di Lorenzo, C. Kaiser, I. Tierala, J. Mehilli, M. Seyfarth, O. Varenne, M.T. Dirksen, G. Percoco, A. Varricchio, U. Pittl, M. Syvanne, M.J. Suttorp, R. Violini, and A. Schomig Meta-analysis of randomized trials on drug-eluting stents vs. baremetal stents in patients with acute myocardial infarction Eur Heart J 28 2007 2706 2713 (Pubitemid 350139205)
81. R. Piccolo, S. Cassese, G. Galasso, R. De Rosa, C. D'Anna, and F. Piscione Long-term safety and efficacy of drug-eluting stents in patients with acute myocardial infarction: a meta-analysis of randomized trials Atherosclerosis 217 2011 149 157
82. G.W. Stone, B. Witzenbichler, G. Guagliumi, J.Z. Peruga, B.R. Brodie, D. Dudek, R. Kornowski, F. Hartmann, B.J. Gersh, S.J. Pocock, G. Dangas, S.C. Wong, M. Fahy, H. Parise, and R. Mehran Heparin plus a glycoprotein IIb/IIIa inhibitor vs. bivalirudin monotherapy and paclitaxel-eluting stents vs. bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial Lancet 377 2011 2193 2204
83. T. Svilaas, P.J. Vlaar, I.C. van der Horst, G.F. Diercks, B.J. de Smet, A.F. van den Heuvel, R.L. Anthonio, G.A. Jessurun, E.S. Tan, A.J. Suurmeijer, and F. Zijlstra Thrombus aspiration during primary percutaneous coronary intervention N Engl J Med 358 2008 557 567 (Pubitemid 351214283)
84. P.J. Vlaar, T. Svilaas, I.C. van der Horst, G.F. Diercks, M.L. Fokkema, B.J. de Smet, A.F. van den Heuvel, R.L. Anthonio, G.A. Jessurun, E.S. Tan, A.J. Suurmeijer, and F. Zijlstra Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study Lancet 371 2008 1915 1920 (Pubitemid 351778190)
85. F. Burzotta, M. De Vita, Y.L. Gu, T. Isshiki, T. Lefevre, A. Kaltoft, D. Dudek, G. Sardella, P.S. Orrego, D. Antoniucci, L. De Luca, G.G. Biondi-Zoccai, F. Crea, and F. Zijlstra Clinical impact of thrombectomy in acute ST-elevation myocardial infarction: an individual patient-data pooled analysis of 11 trials Eur Heart J 30 2009 2193 2203
86. A.A. Bavry, D.J. Kumbhani, and D.L. Bhatt Role of adjunctive thrombectomy and embolic protection devices in acute myocardial infarction: a comprehensive meta-analysis of randomized trials Eur Heart J 29 2008 2989 3001
87. G.W. Stone, A. Maehara, B. Witzenbichler, J. Godlewski, H. Parise, J.H. Dambrink, A. Ochala, T.W. Carlton, E. Cristea, S.D. Wolff, S.J. Brener, S. Chowdhary, M. El-Omar, T. Neunteufl, D.C. Metzger, T. Karwoski, J.M. Dizon, R. Mehran, and C.M. Gibson Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial JAMA 307 2012 1817 1826
88. O. Frobert, B. Lagerqvist, T. Gudnason, L. Thuesen, R. Svensson, G.K. Olivecrona, and S.K. James Thrombus Aspiration in ST-Elevation myocardial infarction in Scandinavia (TASTE trial). A multicenter, prospective, randomized, controlled clinical registry trial based on the Swedish angiography and angioplasty registry (SCAAR) platform. Study design and rationale Am Heart J 160 2010 1042 1048
89. A trial of routine aspiration thrombectomy with percutaneous coronary intervention (PCI) vs. PCI alone in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary PCI (TOTAL). Disponible en: www.clinicaltrials.gov/ct2/show/NCT01149044.
90. H.E. Botker, R. Kharbanda, M.R. Schmidt, M. Bottcher, A.K. Kaltoft, C.J. Terkelsen, K. Munk, N.H. Andersen, T.M. Hansen, S. Trautner, J.F. Lassen, E.H. Christiansen, L.R. Krusell, S.D. Kristensen, L. Thuesen, S.S. Nielsen, M. Rehling, H.T. Sorensen, A.N. Redington, and T.T. Nielsen Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial Lancet 375 2010 727 734
91. P. Staat, G. Rioufol, C. Piot, Y. Cottin, T.T. Cung, I. L'Huillier, J.F. Aupetit, E. Bonnefoy, G. Finet, X. Andre-Fouet, and M. Ovize Postconditioning the human heart Circulation 112 2005 2143 2148 (Pubitemid 41475808)
92. H. Thibault, C. Piot, P. Staat, L. Bontemps, C. Sportouch, G. Rioufol, T.T. Cung, E. Bonnefoy, D. Angoulvant, J.F. Aupetit, G. Finet, X. Andre-Fouet, J.C. Macia, F. Raczka, R. Rossi, R. Itti, G. Kirkorian, G. Derumeaux, and M. Ovize Long-term benefit of postconditioning Circulation 117 2008 1037 1044
93. C. Piot, P. Croisille, P. Staat, H. Thibault, G. Rioufol, N. Mewton, R. Elbelghiti, T.T. Cung, E. Bonnefoy, D. Angoulvant, C. Macia, F. Raczka, C. Sportouch, G. Gahide, G. Finet, X. Andre-Fouet, D. Revel, G. Kirkorian, J.P. Monassier, G. Derumeaux, and M. Ovize Effect of cyclosporine on reperfusion injury in acute myocardial infarction N Engl J Med 359 2008 473 481
94. P. Sorensson, N. Saleh, F. Bouvier, F. Bohm, M. Settergren, K. Caidahl, P. Tornvall, H. Arheden, L. Ryden, and J. Pernow Effect of postconditioning on infarct size in patients with ST elevation myocardial infarction Heart 96 2010 1710 1715
95. X. Freixa, N. Bellera, J.T. Ortiz-Perez, M. Jimenez, C. Pare, X. Bosch, T.M. De Caralt, A. Betriu, and M. Masotti Ischaemic postconditioning revisited: lack of effects on infarct size following primary percutaneous coronary F intervention Eur Heart J 33 2012 103 112
96. J. Lonborg, H. Kelbaek, N. Vejlstrup, E. Jorgensen, S. Helqvist, K. Saunamaki, P. Clemmensen, L. Holmvang, M. Treiman, J.S. Jensen, and T. Engstrom Cardioprotective effects of ischemic postconditioning in patients treated with primary percutaneous coronary intervention, evaluated by magnetic resonance Circ Cardiovasc Interv 3 2010 34 41
97. M.R. Patel, R.W. Smalling, H. Thiele, H.X. Barnhart, Y. Zhou, P. Chandra, D. Chew, M. Cohen, J. French, D. Perera, and E.M. Ohman Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock: the CRISP AMI randomized trial JAMA 306 2011 1329 1337
98. K.D. Sjauw, A.E. Engstrom, M.M. Vis, R.J. van der Schaaf, J. Baan Jr., K.T. Koch, R.J. de Winter, J.J. Piek, J.G. Tijssen, and J.P. Henriques A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines? Eur Heart J 30 2009 459 468
99. M. Cucherat, E. Bonnefoy, and G. Tremeau Primary angioplasty vs. intravenous thrombolysis for acute myocardial infarction Cochrane Database Syst Rev 3 2003 CD001560
100. J.S. Hochman, L.A. Sleeper, J.G. Webb, T.A. Sanborn, H.D. White, J.D. Talley, C.E. Buller, A.K. Jacobs, J.N. Slater, J. Col, S.M. McKinlay, and T.H. LeJemtel Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock N Engl J Med 341 1999 625 634
101. A.J. Nordmann, P. Hengstler, T. Harr, J. Young, and H.C. Bucher Clinical outcomes of primary stenting versus balloon angioplasty in patients with myocardial infarction: a meta-analysis of randomized controlled trials Am J Med 116 2004 253 262 (Pubitemid 38224233)
102. G.W. Stone, B.R. Brodie, J.J. Griffin, C. Costantini, M.C. Morice, F.G. St Goar, P.A. Overlie, J.J. Popma, J. McDonnell, D. Jones, W.W. O'Neill, and C.L. Grines Clinical and angiographic follow-up after primary stenting in acute myocardial infarction: the Primary Angioplasty in Myocardial Infarction (PAMI) stent pilot trial Circulation 99 1999 1548 1554 (Pubitemid 29152920)
103. E.L. Hannan, Z. Samadashvili, G. Walford, D.R. Holmes Jr., A.K. Jacobs, N.J. Stamato, F.J. Venditti, S. Sharma, and S.B. King 3rd. Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease JACC Cardiovasc Interv 3 2010 22 31
104. M. Toma, C.E. Buller, C.M. Westerhout, Y. Fu, W.W. O'Neill, D.R. Holmes Jr., C.W. Hamm, C.B. Granger, and P.W. Armstrong Non-culprit coronary artery percutaneous coronary intervention during acute ST-segment elevation myocardial infarction: insights from the APEX-AMI trial Eur Heart J 31 2010 1701 1707
105. P.J. Vlaar, K.D. Mahmoud, D.R. Holmes Jr., G. van Valkenhoef, H.L. Hillege, I.C. van der Horst, F. Zijlstra, and B.J. de Smet Culprit vessel only versus multivessel and staged percutaneous coronary intervention for multivessel disease in patients presenting with ST-segment elevation myocardial infarction: a pairwise and network meta-analysis J Am Coll Cardiol 58 2011 692 703
106. I. Wijnbergen, H. Helmes, J. Tijssen, G. Brueren, K. Peels, J.M. van Dantzig, M. Van' t Veer, J.J. Koolen, N.H. Pijls, and R. Michels Comparison of drug-eluting and baremetal stents for primary percutaneous coronary intervention with or without abciximab in ST-segment elevation myocardial infarction: DEBATER: the Eindhoven reperfusion study JACC Cardiovasc Interv 5 2012 313 322
107. G. De Luca, M.T. Dirksen, C. Spaulding, H. Kelbaek, M. Schalij, L. Thuesen, B. van der Hoeven, M.A. Vink, C. Kaiser, C. Musto, T. Chechi, G. Spaziani, L.S. Diaz de la Llera, V. Pasceri, E. Di Lorenzo, R. Violini, G. Cortese, H. Suryapranata, and G.W. Stone Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials Arch Intern Med 172 2012 611 621
108. H. Kelbaek, C.J. Terkelsen, S. Helqvist, J.F. Lassen, P. Clemmensen, L. Klovgaard, A. Kaltoft, T. Engstrom, H.E. Botker, K. Saunamaki, L.R. Krusell, E. Jorgensen, H.H. Hansen, E.H. Christiansen, J. Ravkilde, L. Kober, K.F. Kofoed, and L. Thuesen Randomized comparison of distal protection versus conventional treatment in primary percutaneous coronary intervention: the drug elution and distal protection in ST-elevation myocardial infarction (DEDICATION) trial J Am Coll Cardiol 51 2008 899 905 (Pubitemid 351282452)
109. S.D. Wiviott, E. Braunwald, C.H. McCabe, G. Montalescot, W. Ruzyllo, S. Gottlieb, F.J. Neumann, D. Ardissino, S. De Servi, S.A. Murphy, J. Riesmeyer, G. Weerakkody, C.M. Gibson, and E.M. Antman Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015 (Pubitemid 350106708)
110. L. Wallentin, R.C. Becker, A. Budaj, C.P. Cannon, H. Emanuelsson, C. Held, J. Horrow, S. Husted, S. James, H. Katus, K.W. Mahaffey, B.M. Scirica, A. Skene, P.G. Steg, R.F. Storey, R.A. Harrington, A. Freij, and M. Thorsen Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057
111. G. Montalescot, S.D. Wiviott, E. Braunwald, S.A. Murphy, C.M. Gibson, C.H. McCabe, and E.M. Antman Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial Lancet 373 2009 723 731
112. European Public Assessment Report (EPAR): Efient, prasugrel. Disponible en: http://www.ema.europa.eu/docs/en-GB/document-library/EPAR-Product- Information/human/000984/WC500021971.pdf.
113. P.G. Steg, S. James, R.A. Harrington, D. Ardissino, R.C. Becker, C.P. Cannon, H. Emanuelsson, A. Finkelstein, S. Husted, H. Katus, J. Kilhamn, S. Olofsson, R.F. Storey, W.D. Weaver, and L. Wallentin Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: A Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysis Circulation 122 2010 2131 2141
114. R.F. Storey, R.C. Becker, R.A. Harrington, S. Husted, S.K. James, F. Cools, P.G. Steg, N.S. Khurmi, H. Emanuelsson, A. Cooper, R. Cairns, C.P. Cannon, and L. Wallentin Characterization of dyspnoea in PLATO study patients treated with ticagrelor or clopidogrel and its association with clinical outcomes Eur Heart J 32 2011 2945 2953
115. S.R. Mehta, J.F. Tanguay, J.W. Eikelboom, S.S. Jolly, C.D. Joyner, C.B. Granger, D.P. Faxon, H.J. Rupprecht, A. Budaj, A. Avezum, P. Widimsky, P.G. Steg, J.P. Bassand, G. Montalescot, C. Macaya, G. Di Pasquale, K. Niemela, A.E. Ajani, H.D. White, S. Chrolavicius, P. Gao, K.A. Fox, and S. Yusuf Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial Lancet 376 2010 1233 1243
116. S. Koul, J.G. Smith, F. Schersten, S. James, B. Lagerqvist, and D. Erlinge Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention Eur Heart J 32 2011 2989 2997
117. J. Dorler, M. Edlinger, H.F. Alber, J. Altenberger, W. Benzer, G. Grimm, K. Huber, O. Pachinger, H. Schuchlenz, P. Siostrzonek, G. Zenker, and F. Weidinger Clopidogrel pre-treatment is associated with reduced in-hospital mortality in primary percutaneous coronary intervention for acute ST-elevation myocardial infarction Eur Heart J 32 2011 2954 2961
118. S. Yusuf, S.R. Mehta, S. Chrolavicius, R. Afzal, J. Pogue, C.B. Granger, A. Budaj, R.J. Peters, J.P. Bassand, L. Wallentin, C. Joyner, and K.A. Fox Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial JAMA 295 2006 1519 1530
119. J. Silvain, F. Beygui, O. Barthelemy, C. Pollack Jr., M. Cohen, U. Zeymer, K. Huber, P. Goldstein, G. Cayla, J.P. Collet, E. Vicaut, and G. Montalescot Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis Br Med J 344 2012 e553
120. G. Montalescot, S.G. Ellis, M.A. de Belder, L. Janssens, O. Katz, W. Pluta, P. Ecollan, M. Tendera, A.J. van Boven, P. Widimsky, H.R. Andersen, A. Betriu, P. Armstrong, B.R. Brodie, H.C. Herrmann, F.J. Neumann, M.B. Effron, J. Lu, E.S. Barnathan, and E.J. Topol Enoxaparin in primary and facilitated percutaneous coronary intervention A formal prospective nonrandomized substudy of the FINESSE trial (Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events) JACC Cardiovasc Interv 3 2010 203 212
121. E.P. Navarese, G. De Luca, F. Castriota, M. Kozinski, P.A. Gurbel, C.M. Gibson, F. Andreotti, A. Buffon, J.M. Siller-Matula, A. Sukiennik, S. De Servi, and J. Kubica Low-molecular-weight heparins vs. unfractionated heparin in the setting of percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis J Thromb Haemost 9 2011 1902 1915
122. G. Montalescot, U. Zeymer, J. Silvain, B. Boulanger, M. Cohen, P. Goldstein, P. Ecollan, X. Combes, K. Huber, C. Pollack Jr., J.F. Benezet, O. Stibbe, E. Filippi, E. Teiger, G. Cayla, S. Elhadad, F. Adnet, T. Chouihed, S. Gallula, A. Greffet, M. Aout, J.P. Collet, and E. Vicaut Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial Lancet 378 2011 693 703
123. R. Mehran, A.J. Lansky, B. Witzenbichler, G. Guagliumi, J.Z. Peruga, B.R. Brodie, D. Dudek, R. Kornowski, F. Hartmann, B.J. Gersh, S.J. Pocock, S.C. Wong, E. Nikolsky, L. Gambone, L. Vandertie, H. Parise, G.D. Dangas, and G.W. Stone Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial Lancet 374 2009 1149 1159
124. G.W. Stone, B. Witzenbichler, G. Guagliumi, J.Z. Peruga, B.R. Brodie, D. Dudek, R. Kornowski, F. Hartmann, B.J. Gersh, S.J. Pocock, G. Dangas, S.C. Wong, A.J. Kirtane, H. Parise, and R. Mehran Bivalirudin during primary PCI in acute myocardial infarction N Engl J Med 358 2008 2218 2230 (Pubitemid 351724451)
125. G.D. Dangas, A. Caixeta, R. Mehran, H. Parise, A.J. Lansky, E. Cristea, B.R. Brodie, B. Witzenbichler, G. Guagliumi, J.Z. Peruga, D. Dudek, M. Moeckel, and G.W. Stone Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction Circulation 123 2011 1745 1756
126. G. De Luca, E. Navarese, and P. Marino Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials Eur Heart J 30 2009 2705 2713
127. S.G. Ellis, M. Tendera, M.A. de Belder, A.J. van Boven, P. Widimsky, L. Janssens, H.R. Andersen, A. Betriu, S. Savonitto, J. Adamus, J.Z. Peruga, M. Kosmider, O. Katz, T. Neunteufl, J. Jorgova, M. Dorobantu, L. Grinfeld, P. Armstrong, B.R. Brodie, H.C. Herrmann, G. Montalescot, F.J. Neumann, M.B. Effron, E.S. Barnathan, and E.J. Topol Facilitated PCI in patients with ST-elevation myocardial infarction N Engl J Med 358 2008 2205 2217 (Pubitemid 351724450)
128. H.C. Herrmann, J. Lu, B.R. Brodie, P.W. Armstrong, G. Montalescot, A. Betriu, F.J. Neuman, M.B. Effron, E.S. Barnathan, E.J. Topol, and S.G. Ellis Benefit of facilitated percutaneous coronary intervention in high-risk ST-segment elevation myocardial infarction patients presenting to nonpercutaneous coronary intervention hospitals JACC Cardiovasc Interv 2 2009 917 924
129. J.M. Ten Berg, A.W. van' t Hof, T. Dill, T. Heestermans, J.W. van Werkum, A. Mosterd, G. van Houwelingen, P.C. Koopmans, P.R. Stella, E. Boersma, and C. Hamm Effect of early, pre-hospital initiation of high bolus dose tirofiban in patients with ST-segment elevation myocardial infarction on short-and long-term clinical outcome J Am Coll Cardiol 55 2010 2446 2455
130. J. Mehilli, A. Kastrati, S. Schulz, S. Frungel, S.G. Nekolla, W. Moshage, F. Dotzer, K. Huber, J. Pache, J. Dirschinger, M. Seyfarth, S. Martinoff, M. Schwaiger, and A. Schomig Abciximab in patients with acute ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention after clopidogrel loading: a randomized double-blind trial Circulation 119 2009 1933 1940
131. S. Friedland, M.J. Eisenberg, and A. Shimony Meta-analysis of randomized controlled trials of intracoronary versus intravenous administration of glycoprotein IIb/IIIa inhibitors during percutaneous coronary intervention for acute coronary syndrome Am J Cardiol 108 2011 1244 1251
132. H. Thiele, J. Wohrle, R. Hambrecht, H. Rittger, R. Birkemeyer, B. Lauer, P. Neuhaus, O. Brosteanu, P. Sick, M. Wiemer, S. Kerber, K. Kleinertz, I. Eitel, S. Desch, and G. Schuler Intracoronary versus intravenous bolus abciximab during primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: a randomised trial Lancet 379 2012 923 931
133. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet. 1988;2:349-60.
134. C. Patrono, F. Andreotti, H. Arnesen, L. Badimon, C. Baigent, J.P. Collet, R. De Caterina, D. Gulba, K. Huber, S. Husted, S.D. Kristensen, J. Morais, F.J. Neumann, L.H. Rasmussen, A. Siegbahn, P.G. Steg, R.F. Storey, F. Van de Werf, and F. Verheugt Antiplatelet agents for the treatment and prevention of atherothrombosis Eur Heart J 32 2011 2922 2932
135. M.B. Leon, D.S. Baim, J.J. Popma, P.C. Gordon, D.E. Cutlip, K.K. Ho, A. Giambartolomei, D.J. Diver, D.M. Lasorda, D.O. Williams, S.J. Pocock, and R.E. Kuntz A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators N Engl J Med 339 1998 1665 1671 (Pubitemid 28550691)
136. A. Schomig, F.J. Neumann, A. Kastrati, H. Schuhlen, R. Blasini, M. Hadamitzky, H. Walter, E.M. Zitzmann-Roth, G. Richardt, E. Alt, C. Schmitt, and K. Ulm A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents N Engl J Med 334 1996 1084 1089 (Pubitemid 26120185)
137. G. De Luca, H. Suryapranata, G.W. Stone, D. Antoniucci, J.E. Tcheng, F.J. Neumann, F. Van deWerf, E.M. Antman, and E.J. Topol Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials JAMA 293 2005 1759 1765
138. U. Zeymer, A. Margenet, M. Haude, C. Bode, J.M. Lablanche, H. Heuer, R. Schroder, S. Kropff, R. Bourkaib, N. Banik, R. Zahn, and E. Teiger Randomized comparison of eptifibatide versus abciximab in primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: results of the EVA-AMI Trial J Am Coll Cardiol 56 2010 463 469
139. A. Akerblom, S.K. James, M. Koutouzis, B. Lagerqvist, U. Stenestrand, B. Svennblad, and J. Oldgren Eptifibatide is noninferior to abciximab in primary percutaneous coronary intervention: results from the SCAAR (Swedish Coronary Angiography and Angioplasty Registry) J Am Coll Cardiol 56 2010 470 475
140. A.W. Van' t Hof, J. Ten Berg, T. Heestermans, T. Dill, R.C. Funck, W. van Werkum, J.H. Dambrink, H. Suryapranata, G. van Houwelingen, J.P. Ottervanger, P. Stella, E. Giannitsis, and C. Hamm Pre-hospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial Lancet 372 2008 537 546
141. M. Valgimigli, G. Biondi-Zoccai, M. Tebaldi, A.W. van' t Hof, G. Campo, C. Hamm, J. ten Berg, L. Bolognese, F. Saia, G.B. Danzi, C. Briguori, E. Okmen, S.B. King, D.J. Moliterno, and E.J. Topol Tirofiban as adjunctive therapy for acute coronary syndromes and percutaneous coronary intervention: a meta-analysis of randomized trials Eur Heart J 31 2010 35 49
142. G. De Luca, F. Bellandi, K. Huber, M. Noc, A.S. Petronio, H.R. Arntz, M. Maioli, H.M. Gabriel, S. Zorman, M. Dec, T. Rakowski, M. Gyongyosi, and D. Dudek Early glycoprotein IIb-IIIa inhibitors in primary angioplasty-abciximab long-term results (EGYPT-ALT) cooperation: individual patient's data meta-analysis J Thromb Haemost 9 2011 2361 2370
143. Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial. Lancet. 2006;367:569-78.
144. P. Sorajja, B.J. Gersh, C. Costantini, M.G. McLaughlin, P. Zimetbaum, D.A. Cox, E. Garcia, J.E. Tcheng, R. Mehran, A.J. Lansky, D.E. Kandzari, C.L. Grines, and G.W. Stone Combined prognostic utility of ST-segment recovery and myocardial blush after primary percutaneous coronary intervention in acute myocardial infarction Eur Heart J 26 2005 667 674 (Pubitemid 40516878)
145. M.L. Fokkema, P.J. Vlaar, T. Svilaas, M. Vogelzang, D. Amo, G.F. Diercks, A.J. Suurmeijer, and F. Zijlstra Incidence and clinical consequences of distal embolization on the coronary angiogram after percutaneous coronary intervention for ST-elevation myocardial infarction Eur Heart J 30 2009 908 915
146. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Lancet. 1994;343:311-22.
147. H.D. White Thrombolytic therapy in the elderly Lancet 356 2000 2028 2030 (Pubitemid 32009815)
148. Armstrong PW, Gershlick A, Goldstein P, Wilcox R, Danays T, Bluhmki E, Van de Werf F. The Strategic Reperfusion Early After Myocardial Infarction (STREAM) study. Am Heart J. 2010; 160:30-35 e31.
149. F. Van de Werf, H.V. Barron, P.W. Armstrong, C.B. Granger, S. Berioli, G. Barbash, K. Pehrsson, F.W. Verheugt, J. Meyer, A. Betriu, R.M. Califf, X. Li, and N.L. Fox Incidence and predictors of bleeding events after fibrinolytic therapy with fibrin-specific agents: a comparison of TNK-tPA and rt-PA Eur Heart J 22 2001 2253 2261 (Pubitemid 34000980)
150. F. Van De Werf, J. Adgey, D. Ardissino, P.W. Armstrong, P. Aylward, G. Barbash, A. Betriu, A.S. Binbrek, R. Califf, R. Diaz, R. Fanebust, K. Fox, C. Granger, J. Heikkila, S. Husted, P. Jansky, A. Langer, E. Lupi, A. Maseri, J. Meyer, J. Mlczoch, D. Mocceti, D. Myburgh, A. Oto, E. Paolasso, K. Pehrsson, R. Seabra-Gomes, L. Soares-Piegas, D. Sugrue, M. Tendera, E. Topol, P. Toutouzas, A. Vahanian, F. Verheugt, L. Wallentin, and H. White Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 doubleblind randomised trial Lancet 354 1999 716 722 (Pubitemid 29405785)
151. A comparison of reteplase with alteplase for acute myocardial infarction. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators. N Engl J Med. 1997;337:1118-23.
152. S.D. Berkowitz, C.B. Granger, K.S. Pieper, K.L. Lee, J.M. Gore, M. Simoons, P.W. Armstrong, E.J. Topol, and R.M. Califf Incidence and predictors of bleeding after contemporary thrombolytic therapy for myocardial infarction. The Global Utilization of Streptokinase and Tissue Plasminogen activator for Occluded coronary arteries (GUSTO) I Investigators Circulation 95 1997 2508 2516
153. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators. N Engl J Med. 1993;329:673-82.
154. B.W. Bottiger, H.R. Arntz, D.A. Chamberlain, E. Bluhmki, A. Belmans, T. Danays, P.A. Carli, J.A. Adgey, C. Bode, and V. Wenzel Thrombolysis during resuscitation for out-of-hospital cardiac arrest N Engl J Med 359 2008 2651 2662
155. E. Bjorklund, U. Stenestrand, J. Lindback, L. Svensson, L. Wallentin, and B. Lindahl Prehospital thrombolysis delivered by paramedics is associated with reduced time delay and mortality in ambulance-transported real-life patients with ST-elevation myocardial infarction Eur Heart J 27 2006 1146 1152
156. Z.M. Chen, L.X. Jiang, Y.P. Chen, J.X. Xie, H.C. Pan, R. Peto, R. Collins, and L.S. Liu Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial Lancet 366 2005 1607 1621
157. M.S. Sabatine, C.P. Cannon, C.M. Gibson, J.L. Lopez-Sendon, G. Montalescot, P. Theroux, M.J. Claeys, F. Cools, K.A. Hill, A.M. Skene, C.H. McCabe, and E. Braunwald Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation N Engl J Med 352 2005 1179 1189 (Pubitemid 40397259)
158. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction. Lancet. 2001;358:605-13.
159. L. Wallentin, P. Goldstein, P.W. Armstrong, C.B. Granger, A.A. Adgey, H.R. Arntz, K. Bogaerts, T. Danays, B. Lindahl, M. Makijarvi, F. Verheugt, and F. Van deWerf Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the pre-hospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarction Circulation 108 2003 135 142 (Pubitemid 36871293)
160. R.R. Giraldez, J.C. Nicolau, R. Corbalan, E.P. Gurfinkel, U. Juarez, J. Lopez-Sendon, A. Parkhomenko, P. Molhoek, S. Mohanavelu, D.A. Morrow, and E.M. Antman Enoxaparin is superior to unfractionated heparin in patients with ST elevation myocardial infarction undergoing fibrinolysis regardless of the choice of lytic: an ExTRACT-TIMI 25 analysis Eur Heart J 28 2007 1566 1573 (Pubitemid 47227126)
161. H.D. White, E. Braunwald, S.A. Murphy, A.J. Jacob, N. Gotcheva, L. Polonetsky, and E.M. Antman Enoxaparin vs. unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction in elderly and younger patients: results from ExTRACT-TIMI 25 Eur Heart J 28 2007 1066 1071 (Pubitemid 47343884)
162. A.M. Ross, P. Molhoek, C. Lundergan, M. Knudtson, Y. Draoui, L. Regalado, V. Le Louer, F. Bigonzi, W. Schwartz, E. de Jong, and K. Coyne Randomized comparison of enoxaparin, a low-molecular-weight heparin, with unfractionated heparin adjunctive to recombinant tissue plasminogen activator thrombolysis and aspirin: second trial of Heparin and Aspirin Reperfusion Therapy (HART II) Circulation 104 2001 648 652 (Pubitemid 32738517)
163. E.M. Antman, H.W. Louwerenburg, H.F. Baars, J.C. Wesdorp, B. Hamer, J.P. Bassand, F. Bigonzi, G. Pisapia, C.M. Gibson, H. Heidbuchel, E. Braunwald, and F. Van de Werf Enoxaparin as adjunctive antithrombin therapy for ST-elevation myocardial infarction: results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23 Trial Circulation 105 2002 1642 1649 (Pubitemid 34298606)
164. R.J. Peters, C. Joyner, J.P. Bassand, R. Afzal, S. Chrolavicius, S.R. Mehta, J. Oldgren, L. Wallentin, A. Budaj, K.A. Fox, and S. Yusuf The role of fondaparinux as an adjunct to thrombolytic therapy in acute myocardial infarction: a subgroup analysis of the OASIS-6 trial Eur Heart J 29 2008 324 331 (Pubitemid 351197765)
165. A.H. Gershlick, A. Stephens-Lloyd, S. Hughes, K.R. Abrams, S.E. Stevens, N.G. Uren, A. de Belder, J. Davis, M. Pitt, A. Banning, A. Baumbach, M.F. Shiu, P. Schofield, K.D. Dawkins, R.A. Henderson, K.G. Oldroyd, and R. Wilcox Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction N Engl J Med 353 2005 2758 2768 (Pubitemid 43016815)
166. S.G. Ellis, E.R. da Silva, G. Heyndrickx, J.D. Talley, C. Cernigliaro, G. Steg, C. Spaulding, M. Nobuyoshi, R. Erbel, and C. Vassanelli Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute anterior myocardial infarction Circulation 90 1994 2280 2284 (Pubitemid 24354312)
167. J.S. Hochman, L.A. Sleeper, H.D. White, V. Dzavik, S.C. Wong, V. Menon, J.G. Webb, R. Steingart, M.H. Picard, M.A. Menegus, J. Boland, T. Sanborn, C.E. Buller, S. Modur, R. Forman, P. Desvigne-Nickens, A.K. Jacobs, J.N. Slater, and T.H. LeJemtel One-year survival following early revascularization for cardiogenic shock JAMA 285 2001 190 192 (Pubitemid 32048521)
168. W.J. Cantor, D. Fitchett, B. Borgundvaag, J. Ducas, M. Heffernan, E.A. Cohen, L.J. Morrison, A. Langer, V. Dzavik, S.R. Mehta, C. Lazzam, B. Schwartz, A. Casanova, and S.G. Goodman Routine early angioplasty after fibrinolysis for acute myocardial infarction N Engl J Med 360 2009 2705 2718
169. C. Di Mario, D. Dudek, F. Piscione, W. Mielecki, S. Savonitto, E. Murena, K. Dimopoulos, A. Manari, A. Gaspardone, A. Ochala, K. Zmudka, L. Bolognese, P.G. Steg, and M. Flather Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial Lancet 371 2008 559 568 (Pubitemid 351232030)
170. E. Bohmer, P. Hoffmann, M. Abdelnoor, H. Arnesen, and S. Halvorsen Efficacy and safety of immediate angioplasty versus ischemia-guided management after thrombolysis in acute myocardial infarction in areas with very long transfer distances results of the NORDISTEMI (NORwegian study on DIstrict treatment of ST-elevation myocardial infarction) J Am Coll Cardiol 55 2010 102 110
171. F. Fernandez-Aviles, J.J. Alonso, A. Castro-Beiras, N. Vazquez, J. Blanco, J. Alonso-Briales, J. Lopez-Mesa, F. Fernandez-Vazquez, I. Calvo, L. Martinez-Elbal, J.A. San Roman, and B. Ramos Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial Lancet 364 2004 1045 1053 (Pubitemid 39248663)
172. F. Borgia, S.G. Goodman, S. Halvorsen, W.J. Cantor, F. Piscione, M.R. Le May, F. Fernandez-Aviles, P.L. Sanchez, K. Dimopoulos, B. Scheller, P.W. Armstrong, and C. Di Mario Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: a meta-analysis Eur Heart J 31 2010 2156 2169
173. P.L. Sanchez, F. Gimeno, P. Ancillo, J.J. Sanz, J.H. Alonso-Briales, F. Bosa, I. Santos, J. Sanchis, A. Bethencourt, J. Lopez-Messa, A.P. de Prado, J.J. Alonso, J.A. San Roman, and F. Fernandez-Aviles Role of the paclitaxel-eluting stent and tirofiban in patients with ST-elevation myocardial infarction undergoing postfibrinolysis angioplasty: the GRACIA-3 randomized clinical trial Circ Cardiovasc Interv 3 2010 297 307
174. D.P. de Bono, M.L. Simoons, J. Tijssen, A.E. Arnold, A. Betriu, C. Burgersdijk, L. Lopez Bescos, E. Mueller, M. Pfisterer, F. Van deWerf, F. Zijlstra, and M. Verstraete Effect of early intravenous heparin on coronary patency, infarct size, and bleeding complications after alteplase thrombolysis: results of a randomised double blind European Cooperative Study Group trial Br Heart J 67 1992 122 128
175. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. The GUSTO Angiographic Investigators. N Engl J Med. 1993;329:1615-22.
176. H. White Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial Lancet 358 2001 1855 1863 (Pubitemid 34008652)
177. F. Fernandez-Aviles, J.J. Alonso, G. Pena, J. Blanco, J. Alonso-Briales, J. Lopez-Mesa, F. Fernandez-Vazquez, J. Moreu, R.A. Hernandez, A. Castro-Beiras, R. Gabriel, C.M. Gibson, and P.L. Sanchez Primary angioplasty vs. early routine post-fibrinolysis angioplasty for acute myocardial infarction with ST-segment elevation: the GRACIA-2 non-inferiority, randomized, controlled trial Eur Heart J 28 2007 949 960 (Pubitemid 47343896)
178. B. Scheller, B. Hennen, B. Hammer, J. Walle, C. Hofer, V. Hilpert, H. Winter, G. Nickenig, and M. Bohm Beneficial effects of immediate stenting after thrombolysis in acute myocardial infarction J Am Coll Cardiol 42 2003 634 641 (Pubitemid 37000177)
179. M.R. Le May, G.A. Wells, M. Labinaz, R.F. Davies, M. Turek, D. Leddy, J. Maloney, T. McKibbin, B. Quinn, R.S. Beanlands, C. Glover, J.F. Marquis, E.R. O'Brien, W.L. Williams, and L.A. Higginson Combined angioplasty and pharmacological intervention versus thrombolysis alone in acute myocardial infarction (CAPITAL AMI study) J Am Coll Cardiol 46 2005 417 424 (Pubitemid 41040280)
180. S.P. D'Souza, M.A. Mamas, D.G. Fraser, and F. Fath-Ordoubadi Routine early coronary angioplasty versus ischaemia-guided angioplasty after thrombolysis in acute ST-elevation myocardial infarction: a meta-analysis Eur Heart J 32 2011 972 982
181. J.K. Madsen, P. Grande, K. Saunamaki, P. Thayssen, E. Kassis, U. Eriksen, K. Rasmussen, S. Haunso, T.T. Nielsen, T. Haghfelt, P. Fritz-Hansen, E. Hjelms, P.K. Paulsen, P. Alstrup, H. Arendrup, U. Niebuhr-Jorgensen, and L.I. Andersen Danish multicenter randomized study of invasive versus conservative treatment in patients with inducible ischemia after thrombolysis in acute myocardial infarction (DANAMI). DANish trial in Acute Myocardial Infarction Circulation 96 1997 748 755 (Pubitemid 27329605)
182. S. Savonitto, M. D'Urbano, M. Caracciolo, F. Barlocco, G. Mariani, M. Nichelatti, S. Klugmann, and S. De Servi Urgent surgery in patients with a recently implanted coronary drug-eluting stent: a phase II study of 'bridging' antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel Br J Anaesth 104 2010 285 291
183. D.J. Angiolillo, M.S. Firstenberg, M.J. Price, P.E. Tummala, M. Hutyra, I.J. Welsby, M.D. Voeltz, H. Chandna, C. Ramaiah, M. Brtko, L. Cannon, C. Dyke, T. Liu, G. Montalescot, S.V. Manoukian, J. Prats, and E.J. Topol Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial JAMA 307 2012 265 274
184. M. Cohen, G.F. Gensini, F. Maritz, E.P. Gurfinkel, K. Huber, A. Timerman, M. Krzeminska-Pakula, N. Danchin, H.D. White, J. Santopinto, F. Bigonzi, C. Hecquet, and L. Vittori The safety and efficacy of subcutaneous enoxaparin versus intravenous unfractionated heparin and tirofiban versus placebo in the treatment of acute ST-segment elevation myocardial infarction patients ineligible for reperfusion (TETAMI): a randomized trial J Am Coll Cardiol 42 2003 1348 1356 (Pubitemid 37267271)
185. J. Oldgren, L. Wallentin, R. Afzal, J.P. Bassand, A. Budaj, S. Chrolavicius, K.A. Fox, C.B. Granger, S.R. Mehta, P. Pais, R.J. Peters, D. Xavier, J. Zhu, and S. Yusuf Effects of fondaparinux in patients with ST-segment elevation acute myocardial infarction not receiving reperfusion treatment Eur Heart J 29 2008 315 323 (Pubitemid 351197756)
186. P.G. Steg, S.S. Jolly, S.R. Mehta, R. Afzal, D. Xavier, H.J. Rupprecht, J.L. Lopez-Sendon, A. Budaj, R. Diaz, A. Avezum, P. Widimsky, S.V. Rao, S. Chrolavicius, B. Meeks, C. Joyner, J. Pogue, and S. Yusuf Low-dose vs standard-dose unfractionated heparin for percutaneous coronary intervention in acute coronary syndromes treated with fondaparinux: the FUTURA/OASIS-8 randomized trial JAMA 304 2010 1339 1349
187. S. Yusuf, F. Zhao, S.R. Mehta, S. Chrolavicius, G. Tognoni, and K.K. Fox Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502 (Pubitemid 32758501)
188. S.K. James, M.T. Roe, C.P. Cannon, J.H. Cornel, J. Horrow, S. Husted, H. Katus, J. Morais, P.G. Steg, R.F. Storey, S. Stevens, L. Wallentin, and R.A. Harrington Ticagrelor versus clopidogrel in patients with acute coronary syndromes intended for noninvasive management: substudy from prospective
189. D. Brieger, K.A. Eagle, S.G. Goodman, P.G. Steg, A. Budaj, K. White, and G. Montalescot Acute coronary syndromes without chest pain, an underdiagnosed and undertreated high-risk group: insights from the Global Registry of Acute Coronary Events 2004 Chest 136 5 Suppl 2009 e30
190. K.P. Alexander, A.Y. Chen, M.T. Roe, L.K. Newby, C.M. Gibson, N.M. Allen-LaPointe, C. Pollack, W.B. Gibler, E.M. Ohman, and E.D. Peterson Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes JAMA 294 2005 3108 3116 (Pubitemid 43016802)
191. N. Bairey Merz, R.O. Bonow, G. Sopko, R.S. Balaban, R.O. Cannon 3rd, D. Gordon, M.M. Hand, S.N. Hayes, J.F. Lewis, T. Long, T.A. Manolio, A. Maseri, E.G. Nabel, P. Desvigne Nickens, C.J. Pepine, R.F. Redberg, J.E. Rossouw, H.P. Selker, L.J. Shaw, and D.D. Waters Women's Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute workshop: October 2-4, 2002: executive summary Circulation 109 2004 805 807 (Pubitemid 38222904)
192. C. Milcent, B. Dormont, I. Durand-Zaleski, and P.G. Steg Gender differences in hospital mortality and use of percutaneous coronary intervention in acute myocardial infarction: microsimulation analysis of the 1999 nationwide French hospitals database Circulation 115 2007 833 839
193. S.H. Kang, J.W. Suh, C.H. Yoon, M.C. Cho, Y.J. Kim, S.C. Chae, J.H. Yoon, H.C. Gwon, K.R. Han, J.H. Kim, Y.K. Ahn, M.H. Jeong, H.S. Kim, and D.J. Choi Sex Differences in Management and Mortality of Patients With ST-Elevation Myocardial Infarction (from the Korean Acute Myocardial Infarction National Registry) Am J Cardiol 109 2012 787 793
194. Z. Zhang, J. Fang, C. Gillespie, G. Wang, Y. Hong, and P.W. Yoon Age-Specific Gender Differences in In-Hospital Mortality by Type of Acute Myocardial Infarction Am J Cardiol 109 2012 1097 1103
195. J. Mehilli, A. Kastrati, J. Dirschinger, J. Pache, M. Seyfarth, R. Blasini, D. Hall, F.J. Neumann, and A. Schomig Sex-based analysis of outcome in patients with acute myocardial infarction treated predominantly with percutaneous coronary intervention JAMA 287 2002 210 215 (Pubitemid 34251946)
196. K. Szummer, P. Lundman, S.H. Jacobson, S. Schon, J. Lindback, U. Stenestrand, L. Wallentin, and T. Jernberg Relation between renal function, presentation, use of therapies and in-hospital complications in acute coronary syndrome: data from the SWEDEHEART register J Intern Med 268 2010 40 49
197. S. James, A. Budaj, P. Aylward, K.K. Buck, C.P. Cannon, J.H. Cornel, R.A. Harrington, J. Horrow, H. Katus, M. Keltai, B.S. Lewis, K. Parikh, R.F. Storey, K. Szummer, D. Wojdyla, and L. Wallentin Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: results from the Platelet Inhibition and Patient Outcomes (PLATO) trial Circulation 122 2010 1056 1067
198. S.D. Wiviott, E. Braunwald, D.J. Angiolillo, S. Meisel, A.J. Dalby, F.W. Verheugt, S.G. Goodman, R. Corbalan, D.A. Purdy, S.A. Murphy, C.H. McCabe, and E.M. Antman Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38 Circulation 118 2008 1626 1636
199. S. James, D.J. Angiolillo, J.H. Cornel, D. Erlinge, S. Husted, F. Kontny, J. Maya, J.C. Nicolau, J. Spinar, R.F. Storey, S.R. Stevens, and L. Wallentin Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial Eur Heart J 31 2010 3006 3016
200. M. Bartnik, L. Ryden, R. Ferrari, K. Malmberg, K. Pyorala, M. Simoons, E. Standl, J. Soler-Soler, and J. Ohrvik The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart Eur Heart J 25 2004 1880 1890 (Pubitemid 39452604)
201. J.R. Timmer, M. Hoekstra, M.W. Nijsten, I.C. van der Horst, J.P. Ottervanger, R.J. Slingerland, J.H. Dambrink, H.J. Bilo, F. Zijlstra, and A.W. van't Hof Prognostic value of admission glycosylated hemoglobin and glucose in nondiabetic patients with ST-segment-elevation myocardial infarction treated with percutaneous coronary intervention Circulation 124 2011 704 711
202. R. De Caterina, R. Madonna, H. Sourij, and T. Wascher Glycaemic control in acute coronary syndromes: prognostic value and therapeutic options Eur Heart J 31 2010 1557 1564
203. R. Diaz, A. Goyal, S.R. Mehta, R. Afzal, D. Xavier, P. Pais, S. Chrolavicius, J. Zhu, K. Kazmi, L. Liu, A. Budaj, M. Zubaid, A. Avezum, M. Ruda, and S. Yusuf Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction JAMA 298 2007 2399 2405 (Pubitemid 350190781)
204. S. Finfer, D.R. Chittock, S.Y. Su, D. Blair, D. Foster, V. Dhingra, R. Bellomo, D. Cook, P. Dodek, W.R. Henderson, P.C. Hebert, S. Heritier, D.K. Heyland, C. McArthur, E. McDonald, I. Mitchell, J.A. Myburgh, R. Norton, J. Potter, B.G. Robinson, and J.J. Ronco Intensive versus conventional glucose control in critically ill patients N Engl J Med 360 2009 1283 1297
205. L. Ryden, E. Standl, M. Bartnik, G. Van den Berghe, J. Betteridge, M.J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, K. Malmberg, S. Priori, J. Ostergren, J. Tuomilehto, I. Thrainsdottir, I. Vanhorebeek, M. Stramba-Badiale, P. Lindgren, Q. Qiao, S.G. Priori, J.J. Blanc, A. Budaj, J. Camm, V. Dean, J. Deckers, K. Dickstein, J. Lekakis, K. McGregor, M. Metra, J. Morais, A. Osterspey, J. Tamargo, J.L. Zamorano, J.W. Deckers, M. Bertrand, B. Charbonnel, E. Erdmann, E. Ferrannini, A. Flyvbjerg, H. Gohlke, J.R. Juanatey, I. Graham, P.F. Monteiro, K. Parhofer, K. Pyorala, I. Raz, G. Schernthaner, M. Volpe, and D. Wood Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD) Eur Heart J 28 2007 88 136 (Pubitemid 46137814)
206. A. Senthinathan, V. Kelly, M. Dzingina, D. Jones, M. Baker, and D. Longson Hyperglycaemia in acute coronary syndromes: summary of NICE guidance Br Med J 343 2011 d6646
207. M. Kosiborod, and D.K. McGuire Glucose-lowering targets for patients with cardiovascular disease: focus on inpatient management of patients with acute coronary syndromes Circulation 122 2010 2736 2744
208. M. Bartnik, K. Malmberg, A. Norhammar, A. Tenerz, J. Ohrvik, and L. Ryden Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction Eur Heart J 25 2004 1990 1997 (Pubitemid 39486017)
209. Y. Hasin, N. Danchin, G.S. Filippatos, M. Heras, U. Janssens, J. Leor, M. Nahir, A. Parkhomenko, K. Thygesen, M. Tubaro, L.C. Wallentin, and I. Zakke Recommendations for the structure, organization, and operation of intensive cardiac care units Eur Heart J 26 2005 1676 1682 (Pubitemid 41389700)
210. F.A. Spencer, D. Lessard, J.M. Gore, J. Yarzebski, and R.J. Goldberg Declining length of hospital stay for acute myocardial infarction and postdischarge outcomes: a community-wide perspective Arch Intern Med 164 2004 733 740 (Pubitemid 38478695)
211. A.K. Berger, S. Duval, D.R. Jacobs Jr., C. Barber, G. Vazquez, S. Lee, and R.V. Luepker Relation of length of hospital stay in acute myocardial infarction to postdischarge mortality Am J Cardiol 101 2008 428 434 (Pubitemid 351199432)
212. C.L. Grines, D.L. Marsalese, B. Brodie, J. Griffin, B. Donohue, C.R. Costantini, C. Balestrini, G. Stone, T. Wharton, P. Esente, M. Spain, J. Moses, M. Nobuyoshi, M. Ayres, D. Jones, D. Mason, D. Sachs, L.L. Grines, and W. O'Neill Safety and costeffectiveness of early discharge after primary angioplasty in low risk patients with acute myocardial infarction. PAMI-II Investigators. Primary Angioplasty in Myocardial Infarction J Am Coll Cardiol 31 1998 967 972 (Pubitemid 28212494)
213. G. De Luca, H. Suryapranata, A.W. van't Hof, M.J. de Boer, J.C. Hoorntje, J.H. Dambrink, A.T. Gosselink, J.P. Ottervanger, and F. Zijlstra Prognostic assessment of patients with acute myocardial infarction treated with primary angioplasty: implications for early discharge Circulation 109 2004 2737 2743 (Pubitemid 38737921)
214. R. Estevez-Loureiro, R. Calvino-Santos, J.M. Vazquez, E. Barge-Caballero, J. Salgado-Fernandez, M. Pineiro, M. Freire-Tellado, J. Varela-Portas, L. Martinez, S. Gomez, J.A. Rodriguez, N. Vazquez, and A. Castro-Beiras Safety and feasibility of returning patients early to their originating centers after transfer for primary percutaneous coronary intervention Rev Esp Cardiol 62 2009 1356 1364
215. L.K. Newby, V. Hasselblad, P.W. Armstrong, F. Van de Werf, D.B. Mark, H.D. White, E.J. Topol, and R.M. Califf Time-based risk assessment after myocardial infarction. Implications for timing of discharge and applications to medical decision-making Eur Heart J 24 2003 182 189 (Pubitemid 36168473)
216. M.A. Kotowycz, T.L. Cosman, C. Tartaglia, R. Afzal, R.P. Syal, and M.K. Natarajan Safety and feasibility of early hospital discharge in ST-segment elevation myocardial infarction-a prospective and randomized trial in low-risk primary percutaneous coronary intervention patients (the Safe-Depart Trial) Am Heart J 159 2010 117 e111-6
217. D.A. Morrow, E.M. Antman, A. Charlesworth, R. Cairns, S.A. Murphy, J.A. de Lemos, R.P. Giugliano, C.H. McCabe, and E. Braunwald TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudy Circulation 102 2000 2031 2037
218. K.A. Fox, F.A. Anderson Jr., O.H. Dabbous, P.G. Steg, J. Lopez-Sendon, F. Van de Werf, A. Budaj, E.P. Gurfinkel, S.G. Goodman, and D. Brieger Intervention in acute coronary syndromes: do patients undergo intervention on the basis of their risk characteristics? The Global Registry of Acute Coronary Events (GRACE) Heart 93 2007 177 182 (Pubitemid 46180290)
219. K.L. Lee, L.H. Woodlief, E.J. Topol, W.D. Weaver, A. Betriu, J. Col, M. Simoons, P. Aylward, F. Van de Werf, and R.M. Califf Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators Circulation 91 1995 1659 1668
220. K.C. Allman, L.J. Shaw, R. Hachamovitch, and J.E. Udelson Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis J Am Coll Cardiol 39 2002 1151 1158 (Pubitemid 34267418)
221. M. St John Sutton, M.A. Pfeffer, T. Plappert, J.L. Rouleau, L.A. Moye, G.R. Dagenais, G.A. Lamas, M. Klein, B. Sussex, and S. Goldman Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril Circulation 89 1994 68 75 (Pubitemid 24026473)
222. R.S. Beanlands, G. Nichol, E. Huszti, D. Humen, N. Racine, M. Freeman, K.Y. Gulenchyn, L. Garrard, R. deKemp, A. Guo, T.D. Ruddy, F. Benard, A. Lamy, and R.M. Iwanochko F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2) J Am Coll Cardiol 50 2007 2002 2012 (Pubitemid 350054917)
223. G. La Canna, S.H. Rahimtoola, O. Visioli, R. Giubbini, O. Alfieri, M. Zognio, E. Milan, C. Ceconi, M. Gargano, R. Lo Russo, and R. Ferrari Sensitivity, specificity, and predictive accuracies of non-invasive tests, singly and in combination, for diagnosis of hibernating myocardium Eur Heart J 21 2000 1358 1367 (Pubitemid 30599131)
224. J. Perk, G. De Backer, H. Gohlke, I. Graham, Z. Reiner, W.M.M. Verschuren, C. Albus, P. Benlian, G. Boysen, R. Cifkova, C. Deaton, S. Ebrahim, M. Fisher, G. Germano, R. Hobbs, A. Hoes, S. Karadeniz, A. Mezzani, E. Prescott, L. Ryden, M. Scherer, M. Syvanne, W.J. Scholte Op Reimer, C. Vrints, D. Wood, J.L. Zamorano, F. Zannad, M.T. Cooney, J. Bax, H. Baumgartner, C. Ceconi, V. Dean, C. Deaton, R. Fagard, C. Funck-Brentano, D. Hasdai, A. Hoes, P. Kirchhof, J. Knuuti, P. Kolh, T. McDonagh, C. Moulin, B.A. Popescu, Z. Reiner, U. Sechtem, M. Tendera, A. Torbicki, A. Vahanian, S. Windecker, P.A. Sirnes, V. Aboyans, E.A. Ezquerra, C. Baigent, C. Brotons, G. Burell, A. Ceriello, J. De Sutter, J. Deckers, S. Del Prato, H.C. Diener, D. Fitzsimons, Z. Fras, R. Hambrecht, P. Jankowski, U. Keil, M. Kirby, M.L. Larsen, G. Mancia, A.J. Manolis, J. McMurray, A. Pajak, A. Parkhomenko, L. Rallidis, F. Rigo, E. Rocha, L.M. Ruilope, E. van der Velde, D. Vanuzzo, M. Viigimaa, M. Volpe, O. Wiklund, and C. Wolpert The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR) Eur Heart J 33 2012 1635 1701
225. C.C. Thomson, and N.A. Rigotti Hospital-and clinic-based smoking cessation interventions for smokers with cardiovascular disease Prog Cardiovasc Dis 45 2003 459 479 (Pubitemid 36666453)
226. T.J. Meine, M.R. Patel, J.B. Washam, P.A. Pappas, and J.G. Jollis Safety and effectiveness of transdermal nicotine patch in smokers admitted with acute coronary syndromes Am J Cardiol 95 2005 976 978 (Pubitemid 40487750)
227. C.B. Taylor, N. Houston-Miller, J.D. Killen, and R.F. DeBusk Smoking cessation after acute myocardial infarction: effects of a nurse-managed intervention Ann Intern Med 113 1990 118 123 (Pubitemid 20218629)
228. R.S. Taylor, A. Brown, S. Ebrahim, J. Jolliffe, H. Noorani, K. Rees, B. Skidmore, J.A. Stone, D.R. Thompson, and N. Oldridge Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials Am J Med 116 2004 682 692 (Pubitemid 38581114)
229. J. Myers, M. Prakash, V. Froelicher, D. Do, S. Partington, and J.E. Atwood Exercise capacity and mortality among men referred for exercise testing N Engl J Med 346 2002 793 801 (Pubitemid 34987553)
230. S. Bangalore, J. Qin, S. Sloan, S.A. Murphy, and C.P. Cannon What is the optimal blood pressure in patients after acute coronary syndromes?. Relationship of blood pressure and cardiovascular events in the PRavastatin OR atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction (PROVE IT-TIMI) 22 trial Circulation 122 2010 2142 2151
231. M. Gulliksson, G. Burell, B. Vessby, L. Lundin, H. Toss, and K. Svardsudd Randomized controlled trial of cognitive behavioral therapy vs standard treatment to prevent recurrent cardiovascular events in patients with coronary heart disease: Secondary Prevention in Uppsala Primary Health Care project (SUPRIM) Arch Intern Med 171 2011 134 140
232. P.R. Lawler, K.B. Filion, and M.J. Eisenberg Efficacy of exercise-based cardiac rehabilitation post-myocardial infarction: a systematic review and meta-analysis of randomized controlled trials Am Heart J 162 2011 571-584 e572
233. B.S. Heran, J.M. Chen, S. Ebrahim, T. Moxham, N. Oldridge, K. Rees, D.R. Thompson, and R.S. Taylor Exercise-based cardiac rehabilitation for coronary heart disease Cochrane Database Syst Rev 2011 CD001800
234. R.R. West, D.A. Jones, and A.H. Henderson Rehabilitation after myocardial infarction trial (RAMIT): multi-centre randomised controlled trial of comprehensive cardiac rehabilitation in patients following acute myocardial infarction Heart 98 2011 637 644
235. P. Giannuzzi, P.L. Temporelli, R. Marchioli, A.P. Maggioni, G. Balestroni, V. Ceci, C. Chieffo, M. Gattone, R. Griffo, C. Schweiger, L. Tavazzi, S. Urbinati, F. Valagussa, and D. Vanuzzo Global secondary prevention strategies to limit event recurrence after myocardial infarction: results of the GOSPEL study, a multicenter, randomized controlled trial from the Italian Cardiac Rehabilitation Network Arch Intern Med 168 2008 2194 2204
236. H.M. Dalal, A. Zawada, K. Jolly, T. Moxham, and R.S. Taylor Home based versus centre based cardiac rehabilitation: Cochrane systematic review and meta-analysis Br Med J 340 2010 b5631
237. C. Baigent, L. Blackwell, R. Collins, J. Emberson, J. Godwin, R. Peto, J. Buring, C. Hennekens, P. Kearney, T. Meade, C. Patrono, M.C. Roncaglioni, and A. Zanchetti Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials Lancet 373 2009 1849 1860
238. D. Capodanno, A. Patel, K. Dharmashankar, J.L. Ferreiro, M. Ueno, M. Kodali, S.D. Tomasello, P. Capranzano, N. Seecheran, A. Darlington, A. Tello-Montoliu, B. Desai, T.A. Bass, and D.J. Angiolillo Pharmacodynamic effects of different aspirin dosing regimens in type 2 diabetes mellitus patients with coronary artery disease Circ Cardiovasc Interv 4 2011 180 187
239. P. Henry, A. Vermillet, B. Boval, C. Guyetand, T. Petroni, J.G. Dillinger, G. Sideris, C.B. Sollier, and L. Drouet 24-hour time-dependent aspirin efficacy in patients with stable coronary artery disease Thromb Haemost 105 2011 336 344
240. S. Silberman, C. Neukirch-Stoop, and P.G. Steg Rapid desensitization procedure for patients with aspirin hypersensitivity undergoing coronary stenting Am J Cardiol 95 2005 509 510 (Pubitemid 40247551)
241. N.A. Page, and W.S. Schroeder Rapid desensitization protocols for patients with cardiovascular disease and aspirin hypersensitivity in an era of dual antiplatelet therapy Ann Pharmacother 41 2007 61 67 (Pubitemid 46145958)
242. R. Rossini, D.J. Angiolillo, G. Musumeci, P. Scuri, P. Invernizzi, T.A. Bass, L. Mihalcsik, and A. Gavazzi Aspirin desensitization in patients undergoing percutaneous coronary interventions with stent implantation Am J Cardiol 101 2008 786 789
243. A. randomised blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) CAPRIE Steering Committee Lancet 348 1996 1329 1339
244. C.L. Grines, R.O. Bonow, D.E. Casey Jr., T.J. Gardner, P.B. Lockhart, D.J. Moliterno, P. O'Gara, and P. Whitlow Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions. American College of Surgeons, and American Dental Association, with representation from the American College of Physicians Circulation 115 2007 813 818 (Pubitemid 46294748)
245. H.C. Gwon, J.Y. Hahn, K.W. Park, Y.B. Song, I.H. Chae, D.S. Lim, K.R. Han, J.H. Choi, S.H. Choi, H.J. Kang, B.K. Koo, T. Ahn, J.H. Yoon, M.H. Jeong, T.J. Hong, W.Y. Chung, Y.J. Choi, S.H. Hur, H.M. Kwon, D.W. Jeon, B.O. Kim, S.H. Park, N.H. Lee, H.K. Jeon, Y. Jang, and H.S. Kim Six-Month versus Twelve-Month Dual Antiplatelet Therapy after Implantation of Drug-Eluting Stents: 'EXCELLENT' Randomized Multicenter Study Circulation 125 2012 505 513
246. S.J. Park, D.W. Park, Y.H. Kim, S.J. Kang, S.W. Lee, C.W. Lee, K.H. Han, S.W. Park, S.C. Yun, S.G. Lee, S.W. Rha, I.W. Seong, M.H. Jeong, S.H. Hur, N.H. Lee, J. Yoon, J.Y. Yang, B.K. Lee, Y.J. Choi, W.S. Chung, D.S. Lim, S.S. Cheong, K.S. Kim, J.K. Chae, D.Y. Nah, D.S. Jeon, K.B. Seung, J.S. Jang, H.S. Park, and K. Lee Duration of dual antiplatelet therapy after implantation of drug-eluting stents N Engl J Med 362 2010 1374 1382
247. M. Valgimigli, G. Campo, G. Percoco, M. Monti, F. Ferrari, C. Tumscitz, A. Zuffi, F. Colombo, M. Kubbajeh, C. Cavazza, E. Cangiano, M. Tebaldi, M. Minarelli, C. Arcozzi, A. Scalone, A. Frangione, M. Borghesi, J. Marchesini, G. Parrinello, and R. Ferrari Randomized comparison of 6-versus 24-month clopidogrel therapy after balancing anti-intimal hyperplasia stent potency in all-comer patients undergoing percutaneous coronary intervention Design and rationale for the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia study (PRODIGY) Am Heart J 160 2010 804 811
248. L. Mauri, D.J. Kereiakes, S.L. Normand, S.D. Wiviott, D.J. Cohen, D.R. Holmes, S. Bangalore, D.E. Cutlip, M. Pencina, and J.M. Massaro Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, doubleblind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions Am Heart J 160 2010 1035-41 e1031
249. S.R. Mehta, S. Yusuf, R.J. Peters, M.E. Bertrand, B.S. Lewis, M.K. Natarajan, K. Malmberg, H. Rupprecht, F. Zhao, S. Chrolavicius, I. Copland, and K.A. Fox Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study Lancet 358 2001 527 533 (Pubitemid 32772726)
250. A.J. Camm, P. Kirchhof, G.Y. Lip, U. Schotten, I. Savelieva, S. Ernst, I.C. Van Gelder, N. Al-Attar, G. Hindricks, B. Prendergast, H. Heidbuchel, O. Alfieri, A. Angelini, D. Atar, P. Colonna, R. De Caterina, J. De Sutter, A. Goette, B. Gorenek, M. Heldal, S.H. Hohloser, P. Kolh, J.Y. Le Heuzey, P. Ponikowski, and F.H. Rutten Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Eur Heart J 31 2010 2369 2429
251. G.Y. Lip Anticoagulation therapy and the risk of stroke in patients with atrial fibrillation at 'moderate risk' [CHADS2 score=1]: simplifying stroke risk assessment and thromboprophylaxis in real-life clinical practice Thromb Haemost 103 2010 683 685
252. M.L. Hansen, R. Sørensen, M.T. Clausen, M.L. Fog-Petersen, R. J., N. Gadsbøll, G.H. Gislason, F. Folke, S.S. Andersen, T.K. Schramm, S.Z. Abildstrøm, H.E. Poulsen, L. Køber, and C. Torp-Pedersen Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation Arch Intern Med 170 2010 1433 1441
253. G.Y. Lip, K. Huber, F. Andreotti, H. Arnesen, J.K. Airaksinen, T. Cuisset, P. Kirchhof, and F. Marin Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary-a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Eur Heart J 31 2010 1311 1318
254. D.P. Faxon, J.W. Eikelboom, P.B. Berger, D.R. Holmes Jr., D.L. Bhatt, D.J. Moliterno, R.C. Becker, and D.J. Angiolillo Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: a North American perspective: executive summary Circ Cardiovasc Interv 4 2011 522 534
255. A. Rubboli, J.L. Halperin, K.E. Airaksinen, M. Buerke, E. Eeckhout, S.B. Freedman, A.H. Gershlick, A. Schlitt, H.F. Tse, F.W. Verheugt, and G.Y. Lip Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus on atrial fibrillation Ann Med 40 2008 428 436
256. N.S. Abraham, M.A. Hlatky, E.M. Antman, D.L. Bhatt, D.J. Bjorkman, C.B. Clark, C.D. Furberg, D.A. Johnson, C.J. Kahi, L. Laine, K.W. Mahaffey, E.M. Quigley, J. Scheiman, L.S. Sperling, and G.F. Tomaselli ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focussed update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents J Am Coll Cardiol 56 2010 2051 2066
257. M. Gilard, B. Arnaud, J.C. Cornily, G. Le Gal, K. Lacut, G. Le Calvez, J. Mansourati, D. Mottier, J.F. Abgrall, and J. Boschat Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study J Am Coll Cardiol 51 2008 256 260
258. S.G. Goodman, R. Clare, K.S. Pieper, J.C. Nicolau, R.F. Storey, W.J. Cantor, K.W. Mahaffey, D.J. Angiolillo, S. Husted, C.P. Cannon, S.K. James, J. Kilhamn, P.G. Steg, R.A. Harrington, and L. Wallentin Association of Proton Pump Inhibitor Use on Cardiovascular Outcomes with Clopidogrel and Ticagrelor: Insights from PLATO Circulation 125 2012 978 986
259. M.L. O'Donoghue, E. Braunwald, E.M. Antman, S.A. Murphy, E.R. Bates, Y. Rozenman, A.D. Michelson, R.W. Hautvast, P.N. Ver Lee, S.L. Close, L. Shen, J.L. Mega, M.S. Sabatine, and S.D. Wiviott Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials Lancet 374 2009 989 997
260. D.L. Bhatt, B.L. Cryer, C.F. Contant, M. Cohen, A. Lanas, T.J. Schnitzer, T.L. Shook, P. Lapuerta, M.A. Goldsmith, L. Laine, B.M. Scirica, S.A. Murphy, and C.P. Cannon Clopidogrel with or without Omeprazole in Coronary Artery Disease N Engl J Med 363 2010 1909 1917
261. T. Simon, P.G. Steg, M. Gilard, D. Blanchard, L. Bonello, M. Hanssen, H. Lardoux, P. Coste, T. Lefevre, E. Drouet, G. Mulak, V. Bataille, J. Ferrieres, C. Verstuyft, and N. Danchin Clinical events as a function of proton pump inhibitor use, clopidogrel use, and cytochrome P450 2C19 genotype in a large nationwide cohort of acute myocardial infarction: results from the French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) registry Circulation 123 2010 474 482
262. J.L. Mega, E. Braunwald, S.D. Wiviott, J.P. Bassand, D.L. Bhatt, C. Bode, P. Burton, M. Cohen, N. Cook-Bruns, K.A. Fox, S. Goto, S.A. Murphy, A.N. Plotnikov, D. Schneider, X. Sun, F.W. Verheugt, and C.M. Gibson Rivaroxaban in Patients with a Recent Acute Coronary Syndrome N Engl J Med 366 2012 9 19
263. J.H. Alexander, R.D. Lopes, S. James, R. Kilaru, Y. He, P. Mohan, D.L. Bhatt, S. Goodman, F.W. Verheugt, M. Flather, K. Huber, D. Liaw, S.E. Husted, J. Lopez-Sendon, R. De Caterina, P. Jansky, H. Darius, D. Vinereanu, J.H. Cornel, F. Cools, D. Atar, J.L. Leiva-Pons, M. Keltai, H. Ogawa, P. Pais, A. Parkhomenko, W. Ruzyllo, R. Diaz, H. White, M. Ruda, M. Geraldes, J. Lawrence, R.A. Harrington, and L. Wallentin Apixaban with antiplatelet therapy after acute coronary syndrome N Engl J Med 365 2011 699 708
264. P.G. Steg, S.R. Mehta, J.W. Jukema, G.Y. Lip, C.M. Gibson, F. Kovar, P. Kala, A. Garcia-Hernandez, R.W. Renfurm, and C.B. Granger RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome Eur Heart J 32 2011 2541 2554
265. J. Oldgren, A. Budaj, C.B. Granger, Y. Khder, J. Roberts, A. Siegbahn, J.G. Tijssen, F. Van de Werf, and L. Wallentin Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trial Eur Heart J 32 2011 2781 2789
266. Z.M. Chen, H.C. Pan, Y.P. Chen, R. Peto, R. Collins, L.X. Jiang, J.X. Xie, and L.S. Liu Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial Lancet 366 2005 1622 1632
267. C. Baigent, A. Keech, P.M. Kearney, L. Blackwell, G. Buck, C. Pollicino, A. Kirby, T. Sourjina, R. Peto, R. Collins, and R. Simes Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins Lancet 366 2005 1267 1278
268. G.G. Schwartz, A.G. Olsson, M.D. Ezekowitz, P. Ganz, M.F. Oliver, D. Waters, A. Zeiher, and B.R. Chaitman Atorvastatin for acute coronary syndromes JAMA 286 2001 533 535
269. C.P. Cannon, E. Braunwald, C.H. McCabe, D.J. Rader, J.L. Rouleau, R. Belder, S.V. Joyal, K.A. Hill, M.A. Pfeffer, and A.M. Skene Intensive versus moderate lipid lowering with statins after acute coronary syndromes N Engl J Med 350 2004 1495 1504 (Pubitemid 38477774)
270. Z. Reiner, A.L. Catapano, G. De Backer, I. Graham, M.R. Taskinen, O. Wiklund, S. Agewall, E. Alegria, M.J. Chapman, P. Durrington, S. Erdine, J. Halcox, R. Hobbs, J. Kjekshus, P.P. Filardi, G. Riccardi, R.F. Storey, D. Wood, J. Bax, A. Vahanian, A. Auricchio, H. Baumgartner, C. Ceconi, V. Dean, C. Deaton, R. Fagard, G. Filippatos, D. Hasdai, R. Hobbs, A. Hoes, P. Kearney, J. Knuuti, P. Kolh, T. McDonagh, C. Moulin, D. Poldermans, B.A. Popescu, Z. Reiner, U. Sechtem, P.A. Sirnes, M. Tendera, A. Torbicki, P. Vardas, P. Widimsky, S. Windecker, C. Funck-Brentano, G. Berkenboom, J. De Graaf, O. Descamps, N. Gotcheva, K. Griffith, G.F. Guida, S. Gulec, Y. Henkin, K. Huber, Y.A. Kesaniemi, J. Lekakis, A.J. Manolis, P. Marques-Vidal, L. Masana, J. McMurray, M. Mendes, Z. Pagava, T. Pedersen, E. Prescott, Q. Rato, G. Rosano, S. Sans, A. Stalenhoef, L. Tokgozoglu, M. Viigimaa, M.E. Wittekoek, and J.L. Zamorano ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) Eur Heart J 32 2011 1769 1818
271. FDA Drug Safety Communication: New restrictions, contraindications, and dose limitations for Zocor (simvastatin) to reduce the risk of muscle injury. Disponible en: http://www.fda.gov/Drugs/DrugSafety/ucm256581.htm 272. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet. 1999;354:447-55.
272. D. Kromhout, E.J. Giltay, and J.M. Geleijnse n-3 fatty acids cardiovascular events after myocardial infarction N Engl J Med 363 2010 2015 2026
273. B. Rauch, R. Schiele, S. Schneider, F. Diller, N. Victor, H. Gohlke, M. Gottwik, G. Steinbeck, U. Del Castillo, R. Sack, H. Worth, H. Katus, W. Spitzer, G. Sabin, and J. Senges OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction Circulation 122 2010 2152 2159
274. S. Yusuf, P. Held, and C. Furberg Update of effects of calcium antagonists in myocardial infarction or angina in light of the second Danish Verapamil Infarction Trial (DAVIT-II) and other recent studies Am J Cardiol 67 1991 1295 1297
275. Secondary prevention with verapamil after myocardial infarction. The Danish Study Group on Verapamil in Myocardial Infarction. Am J Cardiol. 1990; 66: p33I-40I.
276. Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II-DAVIT II). Am J Cardiol. 1990;66:779-85.
277. P.A. Poole-Wilson, J. Lubsen, B.A. Kirwan, F.J. van Dalen, G. Wagener, N. Danchin, H. Just, K.A. Fox, S.J. Pocock, T.C. Clayton, M. Motro, J.D. Parker, M.G. Bourassa, A.M. Dart, P. Hildebrandt, A. Hjalmarson, J.A. Kragten, G.P. Molhoek, J.E. Otterstad, R. Seabra-Gomes, J. Soler-Soler, and S. Weber Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial Lancet 364 2004 849 857 (Pubitemid 39221062)
278. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. Lancet. 1995;345:669-85.
279. K. Dickstein, and J. Kjekshus Effects of losartan captopril on mortality morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan Lancet 360 2002 752 760 (Pubitemid 35247704)
280. M.A. Pfeffer, J.J. McMurray, E.J. Velazquez, J.L. Rouleau, L. Kober, A.P. Maggioni, S.D. Solomon, K. Swedberg, F. Van de Werf, H. White, J.D. Leimberger, M. Henis, S. Edwards, S. Zelenkofske, M.A. Sellers, and R.M. Califf Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both N Engl J Med 349 2003 1893 1906 (Pubitemid 37409706)
281. B. Pitt, W. Remme, F. Zannad, J. Neaton, F. Martinez, B. Roniker, R. Bittman, S. Hurley, J. Kleiman, and M. Gatlin Eplerenone, a selective
282. S.R. Steinhubl, P.B. Berger, J.T. Mann, 3rd, E.T. Fry, A. DeLago, C. Wilmer, and E.J. Topol Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial JAMA 288 2002 2411 2420 (Pubitemid 35340537)
283. K. Dickstein, A. Cohen-Solal, G. Filippatos, J.J. McMurray, P. Ponikowski, P.A. Poole-Wilson, A. Stromberg, D.J. van Veldhuisen, D. Atar, A.W. Hoes, A. Keren, A. Mebazaa, M. Nieminen, S.G. Priori, and K. Swedberg ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur Heart J 29 2008 2388 2442
284. H.J. Dargie Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial Lancet 357 2001 1385 1390 (Pubitemid 32455364)
285. M. Packer, A.J. Coats, M.B. Fowler, H.A. Katus, H. Krum, P. Mohacsi, J.L. Rouleau, M. Tendera, A. Castaigne, E.B. Roecker, M.K. Schultz, and D.L. DeMets Effect of carvedilol on survival in severe chronic heart failure N Engl J Med 344 2001 1651 1658 (Pubitemid 32479962)
286. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet. 1999;353:9-13.
287. P.A. Poole-Wilson, K. Swedberg, J.G. Cleland, A. Di Lenarda, P. Hanrath, M. Komajda, J. Lubsen, B. Lutiger, M. Metra, W.J. Remme, C. Torp-Pedersen, A. Scherhag, and A. Skene Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial Lancet 362 2003 7 13 (Pubitemid 36835815)
288. K.M. Fox Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebocontrolled, multicentre trial (the EUROPA study) Lancet 362 2003 782 788 (Pubitemid 37093919)
289. S. Yusuf, P. Sleight, J. Pogue, J. Bosch, R. Davies, and G. Dagenais Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.The Heart Outcomes Prevention Evaluation Study Investigators N Engl J Med 342 2000 145 153
290. P.E. Vardas, A. Auricchio, J.J. Blanc, J.C. Daubert, H. Drexler, H. Ector, M. Gasparini, C. Linde, F.B. Morgado, A. Oto, R. Sutton, and M. Trusz-Gluza Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association Eur Heart J 28 2007 2256 2295 (Pubitemid 47428944)
291. R.J. Goldberg, F.A. Spencer, J.M. Gore, D. Lessard, and J. Yarzebski Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective Circulation 119 2009 1211 1219
292. V. Dzavik, L.A. Sleeper, T.P. Cocke, M. Moscucci, J. Saucedo, S. Hosat, X. Jiang, J. Slater, T. LeJemtel, and J.S. Hochman Early revascularization is associated with improved survival in elderly patients with acute myocardial infarction complicated by cardiogenic shock: a report from the SHOCK Trial Registry Eur Heart J 24 2003 828 837 (Pubitemid 36528562)
293. V. Menon, H. White, T. LeJemtel, J.G. Webb, L.A. Sleeper, and J.S. Hochman The clinical profile of patients with suspected cardiogenic shock due to predominant left ventricular failure: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK? J Am Coll Cardiol 36 Suppl A 2000 1071 1076
294. M.H. Picard, R. Davidoff, L.A. Sleeper, L.A. Mendes, C.R. Thompson, V. Dzavik, R. Steingart, K. Gin, H.D. White, and J.S. Hochman Echocardiographic predictors of survival and response to early revascularization in cardiogenic shock Circulation 107 2003 279 284 (Pubitemid 36135224)
295. A.E. Engstrom, M.M. Vis, B.J. Bouma, R.B. van den Brink, J. Baan Jr., B.E. Claessen, W.J. Kikkert, K.D. Sjauw, M. Meuwissen, K.T. Koch, R.J. de Winter, J.G. Tijssen, J.J. Piek, and J.P. Henriques Right ventricular dysfunction is an independent predictor for mortality in ST-elevation myocardial infarction patients presenting with cardiogenic shock on admission Eur J Heart Fail 12 2010 276 282
296. R.V. Jeger, A.M. Lowe, C.E. Buller, M.E. Pfisterer, V. Dzavik, J.G. Webb, J.S. Hochman, and U.P. Jorde Hemodynamic parameters are prognostically important in cardiogenic shock but similar following early revascularization or initial medical stabilization: a report from the SHOCK Trial Chest 132 2007 1794 1803
297. J.H. Alexander, H.R. Reynolds, A.L. Stebbins, V. Dzavik, R.A. Harrington, F. Van de Werf, and J.S. Hochman Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial JAMA 297 2007 1657 1666 (Pubitemid 46631624)
298. S. Thackray, J. Easthaugh, N. Freemantle, and J.G. Cleland The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure-a meta-regression analysis Eur J Heart Fail 4 2002 515 529 (Pubitemid 36564973)
299. D. De Backer, P. Biston, J. Devriendt, C. Madl, D. Chochrad, C. Aldecoa, A. Brasseur, P. Defrance, P. Gottignies, and J.L. Vincent Comparison of dopamine and norepinephrine in the treatment of shock N Engl J Med 362 2010 779 789
300. R.V. Jeger, C.H. Tseng, J.S. Hochman, and E.R. Bates Interhospital transfer for early revascularization in patients with ST-elevation myocardial infarction complicated by cardiogenic shock-a report from the SHould we revascularize Occluded Coronaries for cardiogenic shocK? (SHOCK) trial and registry Am Heart J 52 2006 686 692 (Pubitemid 44396899)
301. F. Hussain, R.K. Philipp, R.A. Ducas, J. Elliott, V. Dzavik, D.S. Jassal, J.W. Tam, D. Roberts, P.J. Garber, and J. Ducas The ability to achieve complete revascularization is associated with improved in-hospital survival in cardiogenic shock due to myocardial infarction: Manitoba cardiogenic SHOCK Registry investigators Catheter Cardiovasc Interv 78 2011 540 548
302. E.M. Ohman, J. Nanas, R.J. Stomel, M.A. Leesar, D.W. Nielsen, D. O'Dea, F.J. Rogers, D. Harber, M.P. Hudson, E. Fraulo, L.K. Shaw, and K.L. Lee Thrombolysis and counterpulsation to improve survival in myocardial infarction complicated by hypotension and suspected cardiogenic shock or heart failure: results of the TACTICS Trial J Thromb Thrombolysis 19 2005 33 39 (Pubitemid 40959212)
303. R. Prondzinsky, H. Lemm, M. Swyter, N. Wegener, S. Unverzagt, J.M. Carter, M. Russ, A. Schlitt, U. Buerke, A. Christoph, H. Schmidt, M. Winkler, J. Thiery, K. Werdan, and M. Buerke Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome Crit Care Med 38 2010 152 160
304. A. Bahekar, M. Singh, S. Singh, R. Bhuriya, K. Ahmad, S. Khosla, and R. Arora Cardiovascular outcomes using intra-aortic balloon pump in high-risk acute myocardial infarction with or without cardiogenic shock: a meta-analysis J Cardiovasc Pharmacol Ther 17 2011 44 56
305. J.M. Cheng, C.A. den Uil, S.E. Hoeks, M. van der Ent, L.S. Jewbali, R.T. van Domburg, and P.W. Serruys Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials Eur Heart J 30 2009 2102 2108
306. R.C. Starling, Y. Naka, A.J. Boyle, G. Gonzalez-Stawinski, R. John, U. Jorde, S.D. Russell, J.V. Conte, K.D. Aaronson, E.C. McGee Jr., W.G. Cotts, D. DeNofrio, D.T. Pham, D.J. Farrar, and F.D. Pagani Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support) J Am Coll Cardiol 57 2011 1890 1898
307. J.J. Sheu, T.H. Tsai, F.Y. Lee, H.Y. Fang, C.K. Sun, S. Leu, C.H. Yang, S.M. Chen, C.L. Hang, Y.K. Hsieh, C.J. Chen, C.J. Wu, and H.K. Yip Early extracorporeal membrane oxygenator-assisted primary percutaneous coronary intervention improved 30-day clinical outcomes in patients with ST-segment elevation myocardial infarction complicated with profound cardiogenic shock Crit Care Med 38 2010 1810 1817
308. F.A. McAlister, S. Stewart, S. Ferrua, and J.J. McMurray Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials J Am Coll Cardiol 44 2004 810 819 (Pubitemid 39099578)
309. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Lancet. 1993;342:821-8.
310. M.A. Pfeffer, E. Braunwald, L.A. Moye, L. Basta, E.J. Brown Jr., T.E. Cuddy, B.R. Davis, E.M. Geltman, S. Goldman, and G.C. Flaker Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators N Engl J Med 327 1992 669 677
311. L. Kober, C. Torp-Pedersen, J.E. Carlsen, H. Bagger, P. Eliasen, K. Lyngborg, J. Videbaek, D.S. Cole, L. Auclert, and N.C. Pauly A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group N Engl J Med 333 1995 1670 1676 (Pubitemid 26001955)
312. A.L. Taylor, S. Ziesche, C. Yancy, P. Carson, R. D'Agostino Jr., K. Ferdinand, M. Taylor, K. Adams, M. Sabolinski, M. Worcel, and J.N. Cohn Combination of isosorbide dinitrate and hydralazine in blacks with heart failure N Engl J Med 351 2004 2049 2057
313. B. Pitt, F. Zannad, W.J. Remme, R. Cody, A. Castaigne, A. Perez, J. Palensky, and J. Wittes The effect of spironolactone on morbidity and mortality in patients with severe heart failure Randomized Aldactone Evaluation Study Investigators N Engl J Med 341 1999 709 717 (Pubitemid 29407370)
314. M.R. Costanzo, M.E. Guglin, M.T. Saltzberg, M.L. Jessup, B.A. Bart, J.R. Teerlink, B.E. Jaski, J.C. Fang, E.D. Feller, G.J. Haas, A.S. Anderson, M.P. Schollmeyer, and P.A. Sobotka Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure J Am Coll Cardiol 49 2007 675 683 (Pubitemid 46205043)
315. M.R. Shah, V. Hasselblad, L.W. Stevenson, C. Binanay, C.M. O'Connor, G. Sopko, and R.M. Califf Impact of the pulmonary artery catheter in critically ill patients: meta-analysis of randomized clinical trials JAMA 294 2005 1664 1670 (Pubitemid 41407359)
316. B. Levy, P. Perez, J. Perny, C. Thivilier, and A. Gerard Comparison of norepinephrinedobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock. A prospective, randomized pilot study Crit Care Med 39 2011 450 455
317. P.E. Bloch Thomsen, C. Jons, M.J. Raatikainen, R. Moerch Joergensen, J. Hartikainen, V. Virtanen, J. Boland, O. Anttonen, U.J. Gang, N. Hoest, L.V. Boersma, E.S. Platou, D. Becker, M.D. Messier, and H.V. Huikuri Long-term recording of cardiac arrhythmias with an implantable cardiac monitor in patients with reduced ejection fraction after acute myocardial infarction: the Cardiac Arrhythmias and Risk Stratification After Acute Myocardial Infarction (CARISMA) study Circulation 122 2010 1258 1264
318. A.T. Askari, M.H. Shishehbor, M.A. Kaminski, M.J. Riley, A. Hsu, and A.M. Lincoff The association between early ventricular arrhythmias, renin-angiotensin-aldosterone system antagonism, and mortality in patients with ST-segment-elevation myocardial infarction: Insights from Global Use of Strategies to Open coronary arteries (GUSTO) V Am Heart J 158 2009 238 243
319. J.P. Piccini, P.M. Hranitzky, R. Kilaru, J.L. Rouleau, H.D. White, P.E. Aylward, F. Van de Werf, S.D. Solomon, R.M. Califf, and E.J. Velazquez Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry) Am J Cardiol 102 2008 1427 1432
320. J. Schmitt, G. Duray, B.J. Gersh, and S.H. Hohnloser Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications Eur Heart J 30 2009 1038 1045
321. P. Jabre, V.L. Roger, M.H. Murad, A.M. Chamberlain, L. Prokop, F. Adnet, and X. Jouven Mortality associated with atrial fibrillation in patients with myocardial infarction: a systematic review and meta-analysis Circulation 123 2011 1587 1593
322. J.B. Segal, R.L. McNamara, M.R. Miller, N. Kim, S.N. Goodman, N.R. Powe, K. Robinson, D. Yu, and E.B. Bass The evidence regarding the drugs used for ventricular rate control J Fam Pract 49 2000 47 59 (Pubitemid 30489236)
323. Z.Y. Hou, M.S. Chang, C.Y. Chen, M.S. Tu, S.L. Lin, H.T. Chiang, and R.L. Woosley Acute treatment of recent-onset atrial fibrillation and flutter with a tailored dosing regimen of intravenous amiodarone. A randomized, digoxin-controlled study Eur Heart J 16 1995 521 528
324. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Blanc JJ, Budaj A, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL, Smith SC Jr., Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death - executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Eur Heart J. 2006;27:2099-140.
325. M.F. Hazinski, J.P. Nolan, J.E. Billi, B.W. Bottiger, L. Bossaert, A.R. de Caen, C.D. Deakin, S. Drajer, B. Eigel, R.W. Hickey, I. Jacobs, M.E. Kleinman, W. Kloeck, R.W. Koster, S.H. Lim, M.E. Mancini, W.H. Montgomery, P.T. Morley, L.J. Morrison, V.M. Nadkarni, R.E. O'Connor, K. Okada, J.M. Perlman, M.R. Sayre, M. Shuster, J. Soar, K. Sunde, A.H. Travers, J. Wyllie, and D. Zideman Part 1: Executive summary: 010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations Circulation 122 Suppl 2 2010 S250 S275
326. K.A. Marill, I.S. deSouza, D.K. Nishijima, E.L. Senecal, G.S. Setnik, T.O. Stair, J.N. Ruskin, and P.T. Ellinor Amiodarone or procainamide for the termination of sustained stable ventricular tachycardia: an historical multicenter comparison Acad Emerg Med 17 2010 297 306
327. M.S. Link, D.L. Atkins, R.S. Passman, H.R. Halperin, R.A. Samson, R.D. White, M.T. Cudnik, M.D. Berg, P.J. Kudenchuk, and R.E. Kerber Part 6: electrical therapies: automated external defibrillators, defibrillation, cardioversion, and pacing: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Circulation 122 Suppl 3 2010 S706 S719
328. L.K. Hine, N. Laird, P. Hewitt, and T.C. Chalmers Meta-analytic evidence against prophylactic use of lidocaine in acute myocardial infarction Arch Intern Med 149 1989 2694 2698 (Pubitemid 20009726)
329. J.P. Piccini, P.J. Schulte, K.S. Pieper, R.H. Mehta, H.D. White, F. Van de Werf, D. Ardissino, R.M. Califf, C.B. Granger, E.M. Ohman, and J.H. Alexander Antiarrhythmic drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarction Crit Care Med 39 2011 78 83
330. J. Brugada, L. Aguinaga, L. Mont, A. Betriu, J. Mulet, and G. Sanz Coronary artery revascularization in patients with sustained ventricular arrhythmias in the chronic phase of a myocardial infarction: effects on the electrophysiologic substrate and outcome J Am Coll Cardiol 37 2001 529 533
331. A. Natale, J. Sra, K. Axtell, C. Maglio, A. Dhala, Z. Blanck, S. Deshpande, M. Jazayeri, and M. Akhtar Ventricular fibrillation and polymorphic ventricular tachycardia with critical coronary artery stenosis: does bypass surgery suffice? J Cardiovasc Electrophysiol 5 1994 988 994
332. D.S. Lee, L.D. Green, P.P. Liu, P. Dorian, D.M. Newman, F.C. Grant, J.V. Tu, and D.A. Alter Effectiveness of implantable defibrillators for preventing arrhythmic events and death: a meta-analysis J Am Coll Cardiol 41 2003 1573 1582 (Pubitemid 36543378)
333. G.H. Bardy, K.L. Lee, D.B. Mark, J.E. Poole, D.L. Packer, R. Boineau, M. Domanski, C. Troutman, J. Anderson, G. Johnson, S.E. McNulty, N. Clapp-Channing, L.D. Davidson-Ray, E.S. Fraulo, D.P. Fishbein, R.M. Luceri, and J.H. Ip Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225 237 (Pubitemid 40110811)
334. K. Dickstein, P.E. Vardas, A. Auricchio, J.C. Daubert, C. Linde, J. McMurray, P. Ponikowski, S.G. Priori, R. Sutton, D.J. van Veldhuisen, A. Vahanian, A. Auricchio, J. Bax, C. Ceconi, V. Dean, G. Filippatos, C. Funck-Brentano, R. Hobbs, P. Kearney, T. McDonagh, B.A. Popescu, Z. Reiner, U. Sechtem, P.A. Sirnes, M. Tendera, P. Vardas, P. Widimsky, M. Tendera, S.D. Anker, J.J. Blanc, M. Gasparini, A.W. Hoes, C.W. Israel, Z. Kalarus, B. Merkely, K. Swedberg, and A.J. Camm 2010 Focussed Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association Eur Heart J 31 2010 2677 2687
335. H.V. Huikuri, M. Cox, A. Interian Jr., K.M. Kessler, F. Glicksman, A. Castellanos, and R.J. Myerburg Efficacy of intravenous propranolol for suppression of inducibility of ventricular tachyarrhythmias with different electrophysiologic characteristics in coronary artery disease Am J Cardiol 64 1989 1305 1309 (Pubitemid 20000080)
336. P. Chevalier, H. Burri, F. Fahrat, M. Cucherat, O. Jegaden, J.F. Obadia, G. Kirkorian, and P. Touboul Perioperative outcome and long-term survival of surgery for acute post-infarction mitral regurgitation Eur J Cardiothorac Surg 26 2004 330 335 (Pubitemid 39024654)
337. O. Topaz, and A.L. Taylor Interventricular septal rupture complicating acute myocardial infarction: from pathophysiologic features to the role of invasive and noninvasive diagnostic modalities in current management Am J Med 93 1992 683 688
338. R. Lemery, H.C. Smith, E.R. Giuliani, and B.J. Gersh Prognosis in rupture of the ventricular septum after acute myocardial infarction and role of early surgical intervention Am J Cardiol 70 1992 147 151
339. M. Imazio, A. Negro, R. Belli, F. Beqaraj, D. Forno, M. Giammaria, R. Trinchero, Y. Adler, and D. Spodick Frequency and prognostic significance of pericarditis following acute myocardial infarction treated by primary percutaneous coronary intervention Am J Cardiol 103 2009 1525 1529
340. A.B. Osherov, M. Borovik-Raz, D. Aronson, Y. Agmon, M. Kapeliovich, A. Kerner, E. Grenadier, H. Hammerman, E. Nikolsky, and A. Roguin Incidence of early left ventricular thrombus after acute anterior wall myocardial infarction in the primary coronary intervention era Am Heart J 157 2009 1074 1080
341. S. Solheim, I. Seljeflot, K. Lunde, R. Bjornerheim, S. Aakhus, K. Forfang, and H. Arnesen Frequency of left ventricular thrombus in patients with anterior wall acute myocardial infarction treated with percutaneous coronary intervention and dual antiplatelet therapy Am J Cardiol 106 2010 1197 1200
342. A. Porter, H. Kandalker, Z. Iakobishvili, A. Sagie, S. Imbar, A. Battler, and D. Hasdai Left ventricular mural thrombus after anterior ST-segment-elevation acute myocardial infarction in the era of aggressive reperfusion therapy-still a frequent complication Coron Artery Dis 16 2005 275 279 (Pubitemid 41073295)
343. G.S. Reeder, M. Lengyel, A.J. Tajik, J.B. Seward, H.C. Smith, and G.K. Danielson Mural thrombus in left ventricular aneurysm: incidence, role of angiography, and relation between anticoagulation and embolization Mayo Clin Proc 56 1981 77 81 (Pubitemid 11185599)
344. E.C. Keeley, and L.D. Hillis Left ventricular mural thrombus after acute myocardial infarction Clin Cardiol 19 1996 83 86 (Pubitemid 26317709)
345. A.G. Turpie, J.G. Robinson, D.J. Doyle, A.S. Mulji, G.J. Mishkel, B.J. Sealey, J.A. Cairns, L. Skingley, J. Hirsh, and M. Gent Comparison of high-dose with low-dose subcutaneous heparin to prevent left ventricular mural thrombosis in patients with acute transmural anterior myocardial infarction N Engl J Med 320 1989 352 357 (Pubitemid 19106871)